1
|
Lindsay JO, Hind D, Swaby L, Berntsson H, Bradburn M, Bannur C U, Byrne J, Clarke C, Desoysa L, Dickins B, Din S, Emsley R, Foulds GA, Gribben J, Hawkey C, Irving PM, Kazmi M, Lee E, Loban A, Lobo A, Mahida Y, Moran GW, Papaioannou D, Parkes M, Peniket A, Pockley AG, Satsangi J, Subramanian S, Travis S, Turton E, Uttenthal B, Rutella S, Snowden JA. Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol 2024; 9:333-345. [PMID: 38340759 DOI: 10.1016/s2468-1253(23)00460-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/18/2023] [Revised: 12/20/2023] [Accepted: 12/20/2023] [Indexed: 02/12/2024]
Abstract
BACKGROUND A previous controlled trial of autologous haematopoietic stem-cell transplantation (HSCT) in patients with refractory Crohn's disease did not meet its primary endpoint and reported high toxicity. We aimed to assess the safety and efficacy of HSCT with an immune-ablative regimen of reduced intensity versus standard of care in this patient population. METHODS This open-label, multicentre, randomised controlled trial was conducted in nine National Health Service hospital trusts across the UK. Adults (aged 18-60 years) with active Crohn's disease on endoscopy (Simplified Endoscopic Score for Crohn's Disease [SES-CD] ulcer sub-score of ≥2) refractory to two or more classes of biological therapy, with no perianal or intra-abdominal sepsis or clinically significant comorbidity, were recruited. Participants were centrally randomly assigned (2:1) to either HSCT with a reduced dose of cyclophosphamide (intervention group) or standard care (control group). Randomisation was stratified by trial site by use of random permuted blocks of size 3 and 6. Patients in the intervention group underwent stem-cell mobilisation (cyclophosphamide 1 g/m2 with granulocyte colony-stimulating factor (G-CSF) 5 μg/kg) and stem-cell harvest (minimum 2·0 × 106 CD34+ cells per kg), before conditioning (fludarabine 125 mg/m2, cyclophosphamide 120 mg/kg, and rabbit anti-thymocyte globulin [thymoglobulin] 7·5 mg/kg in total) and subsequent stem-cell reinfusion supported by G-CSF. Patients in the control group continued any available conventional, biological, or nutritional therapy. The primary outcome was absence of endoscopic ulceration (SES-CD ulcer sub-score of 0) without surgery or death at week 48, analysed in the intention-to-treat population by central reading. This trial is registered with the ISRCTN registry, 17160440. FINDINGS Between Oct 18, 2018, and Nov 8, 2019, 49 patients were screened for eligibility, of whom 23 (47%) were randomly assigned: 13 (57%) to the intervention group and ten (43%) to the control group. In the intervention group, ten (77%) participants underwent HSCT and nine (69%) reached 48-week follow-up; in the control group, nine (90%) reached 48-week follow-up. The trial was halted in response to nine reported suspected unexpected serious adverse reactions in six (46%) patients in the intervention group, including renal failure due to proven thrombotic microangiopathy in three participants and one death due to pulmonary veno-occlusive disease. At week 48, absence of endoscopic ulceration without surgery or death was reported in three (43%) of seven participants in the intervention group and in none of six participants in the control group with available data. Serious adverse events were more frequent in the intervention group (38 in 13 [100%] patients) than in the control group (16 in four [40%] patients). A second patient in the intervention group died after week 48 of respiratory and renal failure. INTERPRETATION Although HSCT with an immune-ablative regimen of reduced intensity decreased endoscopic disease activity, significant adverse events deem this regimen unsuitable for future clinical use in patients with refractory Crohn's disease. FUNDING Efficacy and Mechanism Evaluation Programme, a Medical Research Council and National Institute for Health Research partnership.
Collapse
Affiliation(s)
- James O Lindsay
- Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
| | - Daniel Hind
- Sheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK
| | - Lizzie Swaby
- Sheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK
| | - Hannah Berntsson
- Sheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK
| | - Mike Bradburn
- Sheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK
| | - Uday Bannur C
- Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Jennifer Byrne
- Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Christopher Clarke
- Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Lauren Desoysa
- Sheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK
| | - Ben Dickins
- John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, UK
| | - Shahida Din
- Department of Gastroenterology, Western General Hospital, Edinburgh, UK
| | - Richard Emsley
- Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
| | - Gemma A Foulds
- John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, UK
| | - John Gribben
- Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
| | - Christopher Hawkey
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK; Translational Medical Sciences, School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK
| | - Peter M Irving
- Department of Gastroenterology, Guy's and Saint Thomas' Hospitals NHS Trust, London, UK
| | - Majid Kazmi
- King's College Hospital NHS Foundation Trust, London, UK
| | - Ellen Lee
- Sheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK
| | - Amanda Loban
- Sheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK
| | - Alan Lobo
- Department of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
| | - Yashwant Mahida
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK; Translational Medical Sciences, School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK
| | - Gordon W Moran
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK; Translational Medical Sciences, School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK
| | - Diana Papaioannou
- Sheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK
| | - Miles Parkes
- Department of Medicine, University of Cambridge, Cambridge, UK
| | - Andrew Peniket
- Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - A Graham Pockley
- John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, UK
| | - Jack Satsangi
- NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
| | | | - Simon Travis
- NIHR Biomedical Research Centre, Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK
| | - Emily Turton
- Sheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK
| | - Ben Uttenthal
- Department of Clinical Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Sergio Rutella
- John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, UK
| | - John A Snowden
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
| |
Collapse
|
2
|
Rapaport P, Amador S, Adeleke M, Banerjee S, Barber J, Charlesworth G, Clarke C, Connell C, Espie C, Gonzalez L, Horsley R, Hunter R, Kyle SD, Manela M, Morris S, Pikett L, Raczek M, Thornton E, Walker Z, Webster L, Livingston G. Clinical and cost-effectiveness of DREAMS START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives) for people living with dementia and their carers: a study protocol for a parallel multicentre randomised controlled trial. BMJ Open 2024; 14:e075273. [PMID: 38307536 PMCID: PMC10836385 DOI: 10.1136/bmjopen-2023-075273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Accepted: 01/19/2024] [Indexed: 02/04/2024] Open
Abstract
INTRODUCTION Many people living with dementia experience sleep disturbance and there are no known effective treatments. Non-pharmacological treatment options should be the first-line sleep management. For family carers, relatives' sleep disturbance leads to interruption of their sleep, low mood and breakdown of care. Our team developed and delivered DREAMS START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives), a multimodal non-pharmacological intervention, showing it to be feasible and acceptable. The aim of this randomised controlled trial is to establish whether DREAMS START is clinically cost-effective in reducing sleep disturbances in people living with dementia living at home compared with usual care. METHODS AND ANALYSIS We will recruit 370 participant dyads (people living with dementia and family carers) from memory services, community mental health teams and the Join Dementia Research Website in England. Those meeting inclusion criteria will be randomised (1:1) either to DREAMS START or to usual treatment. DREAMS START is a six-session (1 hour/session), manualised intervention delivered every 1-2 weeks by supervised, non-clinically trained graduates. Outcomes will be collected at baseline, 4 months and 8 months with the primary outcome being the Sleep Disorders Inventory score at 8 months. Secondary outcomes for the person with dementia (all proxy) include quality of life, daytime sleepiness, neuropsychiatric symptoms and cost-effectiveness. Secondary outcomes for the family carer include quality of life, sleep disturbance, mood, burden and service use and caring/work activity. Analyses will be intention-to-treat and we will conduct a process evaluation. ETHICS AND DISSEMINATION London-Camden & Kings Cross Ethics Committee (20/LO/0894) approved the study. We will disseminate our findings in high-impact peer-reviewed journals and at national and international conferences. This research has the potential to improve sleep and quality of life for people living with dementia and their carers, in a feasible and scalable intervention. TRIAL REGISTRATION NUMBER ISRCTN13072268.
Collapse
Affiliation(s)
- Penny Rapaport
- Division of Psychiatry, University College London, London, UK
| | - Sarah Amador
- Division of Psychiatry, University College London, London, UK
| | - Mariam Adeleke
- Department of Statistical Science, University College London, London, UK
| | - Sube Banerjee
- Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK
| | - Julie Barber
- Department of Statistical Science, University College London, London, UK
| | - Georgina Charlesworth
- Division of Psychology and Language Sciences, University College London, London, UK
- North East London NHS Foundation Trust, Rainham, UK
| | | | | | - Colin Espie
- Sleep and Circadian Neuroscience Institute, University of Oxford, Oxford, UK
| | - Lina Gonzalez
- Research Department of Primary Care and Population Health, University College London, London, UK
| | | | - Rachael Hunter
- Research Department of Primary Care and Population Health, University College London, London, UK
| | - Simon D Kyle
- Sleep and Circadian Neuroscience Institute, University of Oxford, Oxford, UK
| | - Monica Manela
- Division of Psychiatry, University College London, London, UK
| | - Sarah Morris
- Tees Esk and Wear Valleys NHS Foundation Trust, Darlington, UK
| | - Liam Pikett
- Division of Psychiatry, University College London, London, UK
| | - Malgorzata Raczek
- Centre for Dementia Studies, Brighton and Sussex Medical School, Brighton, UK
| | - Emma Thornton
- Tees Esk and Wear Valleys NHS Foundation Trust, Darlington, UK
| | - Zuzana Walker
- Division of Psychiatry, University College London, London, UK
| | - Lucy Webster
- Division of Psychiatry, University College London, London, UK
| | - Gill Livingston
- Division of Psychiatry, University College London, London, UK
| |
Collapse
|
3
|
Robinson E, Balasubramaniam R, Hameed M, Clarke C, Taylor SA, Tolan D, Foley KG. Survey of rectal cancer MRI technique and reporting tumour descriptors in the UK: a multi-centre British Society of Gastrointestinal and Abdominal Radiology (BSGAR) audit. Clin Radiol 2024; 79:117-123. [PMID: 37989667 DOI: 10.1016/j.crad.2023.10.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 10/17/2023] [Accepted: 10/21/2023] [Indexed: 11/23/2023]
Abstract
AIM To evaluate variation in magnetic resonance imaging (MRI) technique and reporting of rectal cancer staging examinations across the UK. MATERIALS AND METHODS A retrospective, multi-centre audit was undertaken of imaging protocols and information documented within consecutive MRI rectal cancer reports between March 2020 and August 2021, which were compared against American and European guidelines. Inclusion criteria included histologically proven rectal adenocarcinoma and baseline staging MRI rectum only. RESULTS Fully anonymised data from 924 MRI reports by 78 radiologists at 24 centres were evaluated. Thirty-two per cent of radiologists used template reporting, but these reports offered superior documentation of 13 out of 18 key tumour features compared to free-text reports including T-stage, relation to peritoneal reflection and mesorectal fascia (MRF), nodal status, and presence of extramural venous invasion (EMVI; p<0.027 in each). There was no significant differences in the remaining five features. Across all tumour locations, the tumour relationship to the MRF, the presence of EMVI, and the presence of tumour deposits were reported in 79.5%, 85.6%, and 44% of cases, respectively, and tumour, nodal, and distant metastatic stage documented in 94.4%, 97.7%, and 78.3%. In low rectal tumours, the relationship to the anal sphincter complex was reported in only 54.6%. CONCLUSION Considerable variation exists in rectal cancer MRI acquisition and reporting in this sample of UK centres. Inclusion of key radiological features in reports must be improved for risk stratification and treatment decisions. Template reporting is superior to free-text reporting. Routine adoption of standardised radiology practices should now be considered to improve standards to facilitate personalised precision treatment for patients to improve outcomes.
Collapse
Affiliation(s)
- E Robinson
- North Bristol NHS Trust, Southmead Road, Westbury-on-Trym Bristol, BS10 5NB, UK.
| | - R Balasubramaniam
- Royal Stoke University Hospital, Newcastle Road, Stoke-on-Trent, Staffordshire, ST4 6QG, UK
| | - M Hameed
- University College Hospital, 235 Euston Road, London, NW1 2BU, UK; University College London, Centre for Medical Imaging, 2nd Floor Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK
| | - C Clarke
- Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, Nottinghamshire, NG7 2UH, UK
| | - S A Taylor
- University College London, Centre for Medical Imaging, 2nd Floor Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK
| | - D Tolan
- Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF, UK.
| | - K G Foley
- Royal Glamorgan Hospital, Ynysmaerdy, Llantrisant, UK; Velindre Cancer Centre, Velindre Road, Whitchurch, Cardiff, CF14 2TL, UK
| |
Collapse
|
4
|
Tuckey AN, Brandon A, Eslaamizaad Y, Siddiqui W, Nawaz T, Clarke C, Sutherland E, Williams V, Spadafora D, Barrington RA, Alvarez DF, Mulekar MS, Simmons JD, Fouty BW, Audia JP. Amyloid-β and caspase-1 are indicators of sepsis and organ injury. ERJ Open Res 2024; 10:00572-2023. [PMID: 38410714 PMCID: PMC10895426 DOI: 10.1183/23120541.00572-2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 12/04/2023] [Indexed: 02/28/2024] Open
Abstract
Background Sepsis is a life-threatening condition that results from a dysregulated host response to infection, leading to organ dysfunction. Despite the prevalence and associated socioeconomic costs, treatment of sepsis remains limited to antibiotics and supportive care, and a majority of intensive care unit (ICU) survivors develop long-term cognitive complications post-discharge. The present study identifies a novel regulatory relationship between amyloid-β (Aβ) and the inflammasome-caspase-1 axis as key innate immune mediators that define sepsis outcomes. Methods Medical ICU patients and healthy individuals were consented for blood and clinical data collection. Plasma cytokine, caspase-1 and Aβ levels were measured. Data were compared against indices of multiorgan injury and other clinical parameters. Additionally, recombinant proteins were tested in vitro to examine the effect of caspase-1 on a functional hallmark of Aβ, namely aggregation. Results Plasma caspase-1 levels displayed the best predictive value in discriminating ICU patients with sepsis from non-infected ICU patients (area under the receiver operating characteristic curve=0.7080). Plasma caspase-1 and the Aβ isoform Aβx-40 showed a significant positive correlation and Aβx-40 associated with organ injury. Additionally, Aβ plasma levels continued to rise from time of ICU admission to 7 days post-admission. In silico, Aβ harbours a predicted caspase-1 cleavage site, and in vitro studies demonstrated that caspase-1 cleaved Aβ to inhibit its auto-aggregation, suggesting a novel regulatory relationship. Conclusions Aβx-40 and caspase-1 are potentially useful early indicators of sepsis and its attendant organ injury. Additionally, Aβx-40 has emerged as a potential culprit in the ensuing development of post-ICU syndrome.
Collapse
Affiliation(s)
- Amanda N. Tuckey
- Department of Microbiology and Immunology, University of South Alabama College of Medicine
- Center for Lung Biology, University of South Alabama College of Medicine
| | - Arcole Brandon
- Center for Lung Biology, University of South Alabama College of Medicine
| | - Yasaman Eslaamizaad
- Department of Internal Medicine, University of South Alabama College of Medicine
- Division of Pulmonary and Critical Care Medicine, University of South Alabama College of Medicine
| | - Waqar Siddiqui
- Department of Internal Medicine, University of South Alabama College of Medicine
- Division of Pulmonary and Critical Care Medicine, University of South Alabama College of Medicine
| | - Talha Nawaz
- Department of Internal Medicine, University of South Alabama College of Medicine
- Division of Pulmonary and Critical Care Medicine, University of South Alabama College of Medicine
| | - Christopher Clarke
- Department of Internal Medicine, University of South Alabama College of Medicine
- Division of Pulmonary and Critical Care Medicine, University of South Alabama College of Medicine
| | - Erica Sutherland
- Department of Internal Medicine, University of South Alabama College of Medicine
| | - Veronica Williams
- Department of Laboratory Medicine, University of South Alabama University Hospital
| | - Domenico Spadafora
- Flow Cytometry Shared Resources Laboratory, University of South Alabama College of Medicine
| | - Robert A. Barrington
- Department of Microbiology and Immunology, University of South Alabama College of Medicine
- Center for Lung Biology, University of South Alabama College of Medicine
- Flow Cytometry Shared Resources Laboratory, University of South Alabama College of Medicine
| | - Diego F. Alvarez
- Center for Lung Biology, University of South Alabama College of Medicine
- Department of Internal Medicine, University of South Alabama College of Medicine
- Department of Pharmacology College of Medicine, University of South Alabama College of Medicine
| | - Madhuri S. Mulekar
- Department of Mathematics and Statistics, University of South Alabama College of Arts and Sciences
| | - Jon D. Simmons
- Center for Lung Biology, University of South Alabama College of Medicine
- Department of Pharmacology College of Medicine, University of South Alabama College of Medicine
- Department of Surgery, University of South Alabama College of Medicine
| | - Brian W. Fouty
- Center for Lung Biology, University of South Alabama College of Medicine
- Department of Internal Medicine, University of South Alabama College of Medicine
- Division of Pulmonary and Critical Care Medicine, University of South Alabama College of Medicine
- Department of Pharmacology College of Medicine, University of South Alabama College of Medicine
| | - Jonathon P. Audia
- Department of Microbiology and Immunology, University of South Alabama College of Medicine
- Center for Lung Biology, University of South Alabama College of Medicine
| |
Collapse
|
5
|
Morgan R, Haslam P, McCafferty I, Bryant T, Clarke C, McPherson S, Wells D, Gupta Y, See TC, Lakshminarayan R, Miller F, Scott P, Almazedi B, Bardgett H, Barnacle A, Shaida N, Manoharan D, Lewis M, Taylor J, Bhat R, Shaygi B, Ratnam L. Provision of Interventional Radiology Services 2023. Cardiovasc Intervent Radiol 2024; 47:3-25. [PMID: 37978066 PMCID: PMC10770229 DOI: 10.1007/s00270-023-03600-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 10/17/2023] [Indexed: 11/19/2023]
Affiliation(s)
| | | | | | - Timothy Bryant
- University Hospitals Southampton NHS Foundation Trust, Southampton, UK
| | | | | | - David Wells
- University Hospitals of the North Midlands NHS Trust, Stoke-On-Trent, UK
| | - Yuri Gupta
- University Hospitals Sussex NHS Foundation Trust, Brighton, UK
| | - Teik Choon See
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | | | | | - Paul Scott
- Hull University Teaching Hospitals, Hull, UK
| | | | | | - Alex Barnacle
- Great Ormond Street Hospital for Children, London, UK
| | - Nadeem Shaida
- Cambridge University NHS Foundation Trust, Cambridge, UK
| | - Dinesh Manoharan
- Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
| | - Mark Lewis
- Norfolk and Norwich University Hospitals NHS Trust, Norwich, UK
| | - Jeremy Taylor
- Frimley Health Foundation Trust, Surrey, Frimley, UK
| | - Rajesh Bhat
- Ninewells Hospital and Medical School, Dundee, UK
| | - Behnam Shaygi
- London North West University Healthcare NHS Trust, London, UK
| | | |
Collapse
|
6
|
Goins SM, Jiang H, van der Pol CB, Salameh JP, Lam E, Adamo RG, McInnes MDF, Costa AF, Clarke C, Choi SH, Fraum TJ, Ludwig DR, Song B, Joo I, Kierans AS, Kim SY, Kwon H, Podgórska J, Rosiak G, Bashir MR. Comparative Performance of 2018 LI-RADS versus Modified LIRADS (mLI-RADS): An Individual Participant Data Meta-Analysis. J Magn Reson Imaging 2023. [PMID: 38038346 DOI: 10.1002/jmri.29167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Revised: 11/17/2023] [Accepted: 11/17/2023] [Indexed: 12/02/2023] Open
Abstract
BACKGROUND LI-RADS version 2018 (v2018) is used for non-invasive diagnosis of hepatocellular carcinoma (HCC). A recently proposed modification (known as mLI-RADS) demonstrated improved sensitivity while maintaining specificity and positive predictive value (PPV) of LI-RADS category 5 (definite HCC) for HCC. However, mLI-RADS requires multicenter validation. PURPOSE To evaluate the performance of v2018 and mLI-RADS for liver lesions in a large, heterogeneous, multi-national cohort of patients at risk for HCC. STUDY TYPE Systematic review and meta-analysis using individual participant data (IPD) [Study Protocol: https://osf.io/duys4]. POPULATION 2223 observations from 1817 patients (includes all LI-RADS categories; females = 448, males = 1361, not reported = 8) at elevated risk for developing HCC (based on LI-RADS population criteria) from 12 retrospective studies. FIELD STRENGTH/SEQUENCE 1.5T and 3T; complete liver MRI with gadoxetate disodium, including axial T2w images and dynamic axial fat-suppressed T1w images precontrast and in the arterial, portal venous, transitional, and hepatobiliary phases. Diffusion-weighted imaging was used when available. ASSESSMENT Liver observations were categorized using v2018 and mLI-RADS. The diagnostic performance of each system's category 5 (LR-5 and mLR-5) for HCC were compared. STATISTICAL TESTS The Quality Assessment of Diagnostic Accuracy Studies version 2 (QUADAS-2 was applied to determine risk of bias and applicability. Diagnostic performances were assessed using the likelihood ratio test for sensitivity and specificity and the Wald test for PPV. The significance level was P < 0.05. RESULTS 17% (2/12) of the studies were considered low risk of bias (244 liver observations; 164 patients). When compared to v2018, mLR-5 demonstrated higher sensitivity (61.3% vs. 46.5%, P < 0.001), similar PPV (85.3% vs. 86.3%, P = 0.89), and similar specificity (85.8% vs. 90.8%, P = 0.16) for HCC. DATA CONCLUSION This study confirms mLR-5 has higher sensitivity than LR-5 for HCC identification, while maintaining similar PPV and specificity, validating the mLI-RADS proposal in a heterogeneous, international cohort. LEVEL OF EVIDENCE 3 TECHNICAL EFFICACY: Stage 2.
Collapse
Affiliation(s)
- Stacy M Goins
- Duke University School of Medicine, Durham, North Carolina, USA
| | - Hanyu Jiang
- Department of Radiology, West China Hospital, Sichuan University, Chengdu, China
| | - Christian B van der Pol
- Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
| | - Jean-Paul Salameh
- Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada
| | - Eric Lam
- Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
| | - Robert G Adamo
- Faculty of Medicine, The University of Ottawa, Ottawa, Ontario, Canada
| | - Matthew D F McInnes
- Departments of Radiology and Epidemiology uOttawa, The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada
| | - Andreu F Costa
- Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada
| | - Christopher Clarke
- Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Sang Hyun Choi
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Tyler J Fraum
- Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
| | - Daniel R Ludwig
- Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
| | - Bin Song
- Department of Radiology, Sichuan University West China Hospital, Chengdu, Sichuan, China
| | - Ijin Joo
- Department of Radiology, Seoul National University College of Medicine, Seoul, Korea
| | | | - So Yeon Kim
- Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
| | - Heejin Kwon
- Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Republic of Korea
| | - Joanna Podgórska
- Second Radiology Department, Warsaw Medical University, Warsaw, Poland
| | - Grzegorz Rosiak
- Second Radiology Department, Warsaw Medical University, Warsaw, Poland
| | - Mustafa R Bashir
- Departments of Radiology and Medicine, Duke University Medical Center, Durham, North Carolina, USA
- Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, North Carolina, USA
- Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, USA
| |
Collapse
|
7
|
Goins SM, Jiang H, van der Pol CB, Salameh JP, Lam E, Adamo RG, McInnes MDF, Costa AF, Tang A, Alhasan AS, Allen BC, Reiner CS, Clarke C, Cerny M, Wang J, Choi SH, Fraum TJ, Ludwig DR, Song B, Joo I, Kang Z, Kierans AS, Kim SY, Kwon H, Ronot M, Podgórska J, Rosiak G, Song JS, Bashir MR. Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis. Radiology 2023; 309:e231656. [PMID: 38112549 DOI: 10.1148/radiol.231656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2023]
Abstract
Background A simplification of the Liver Imaging Reporting and Data System (LI-RADS) version 2018 (v2018), revised LI-RADS (rLI-RADS), has been proposed for imaging-based diagnosis of hepatocellular carcinoma (HCC). Single-site data suggest that rLI-RADS category 5 (rLR-5) improves sensitivity while maintaining positive predictive value (PPV) of the LI-RADS v2018 category 5 (LR-5), which indicates definite HCC. Purpose To compare the diagnostic performance of LI-RADS v2018 and rLI-RADS in a multicenter data set of patients at risk for HCC by performing an individual patient data meta-analysis. Materials and Methods Multiple databases were searched for studies published from January 2014 to January 2022 that evaluated the diagnostic performance of any version of LI-RADS at CT or MRI for diagnosing HCC. An individual patient data meta-analysis method was applied to observations from the identified studies. Quality Assessment of Diagnostic Accuracy Studies version 2 was applied to determine study risk of bias. Observations were categorized according to major features and either LI-RADS v2018 or rLI-RADS assignments. Diagnostic accuracies of category 5 for each system were calculated using generalized linear mixed models and compared using the likelihood ratio test for sensitivity and the Wald test for PPV. Results Twenty-four studies, including 3840 patients and 4727 observations, were analyzed. The median observation size was 19 mm (IQR, 11-30 mm). rLR-5 showed higher sensitivity compared with LR-5 (70.6% [95% CI: 60.7, 78.9] vs 61.3% [95% CI: 45.9, 74.7]; P < .001), with similar PPV (90.7% vs 92.3%; P = .55). In studies with low risk of bias (n = 4; 1031 observations), rLR-5 also achieved a higher sensitivity than LR-5 (72.3% [95% CI: 63.9, 80.1] vs 66.9% [95% CI: 58.2, 74.5]; P = .02), with similar PPV (83.1% vs 88.7%; P = .47). Conclusion rLR-5 achieved a higher sensitivity for identifying HCC than LR-5 while maintaining a comparable PPV at 90% or more, matching the results presented in the original rLI-RADS study. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Sirlin and Chernyak in this issue.
Collapse
Affiliation(s)
- Stacy M Goins
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Hanyu Jiang
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Christian B van der Pol
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Jean-Paul Salameh
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Eric Lam
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Robert G Adamo
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Matthew D F McInnes
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Andreu F Costa
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - An Tang
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Ayman S Alhasan
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Brian C Allen
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Caecilia S Reiner
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Christopher Clarke
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Milena Cerny
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Jin Wang
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Sang Hyun Choi
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Tyler J Fraum
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Daniel R Ludwig
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Bin Song
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Ijin Joo
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Zhen Kang
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Andrea S Kierans
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - So Yeon Kim
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Heejin Kwon
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Maxime Ronot
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Joanna Podgórska
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Grzegorz Rosiak
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Ji Soo Song
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| | - Mustafa R Bashir
- From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Department of Radiology, West China Hospital, Sichuan University, Chengdu, China (H.J., B.S.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada (J.P.S.); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (E.L.); Faculty of Medicine at The University of Ottawa, Ottawa, Ontario, Canada (R.G.A.); Departments of Radiology and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada (M.D.F.M.); The Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada (M.D.F.M.); Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (A.F.C.); Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (A.T.); Department of Radiology, College of Medicine, Taibah University, Medina, Saudi Arabia (A.S.A.); Department of Radiology, King Faisal Specialist Hospital and Research Centre, Medina, Saudi Arabia (A.S.A.); Department of Radiology, Duke University Medical Center, Durham, NC (B.C.A.); Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland (C.S.R.); Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom (C.C.); Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (M.C.); Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China (J.W.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.H.C.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.J.F., D.R.L.); Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea (I.J.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, China (Z.K.); Weill Cornell Medical Center, New York, NY (A.S.K.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea (S.Y.K.); Department of Radiology, Dong-A University Hospital, Dong-A University College of Medicine, Seo-gu, Busan, South Korea (H.K.); Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy and Université Paris Cité, CRI UMR 1149, Paris, France (M.R.); Second Radiology Department, Warsaw Medical University, Warsaw, Poland (J.P., G.R.); Department of Radiology, Jeonbuk National University Medical School and Hospital, Deokjin-gu, Jeonju, Jeonbuk, South Korea (J.S.S.); Departments of Radiology and Medicine, Duke University Medical Center, 40 Duke Medicine Cir, Durham, NC, 27710 (M.R.B.); Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, NC (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.)
| |
Collapse
|
8
|
Agarwal S, Munyal R, Aravinthan A, Clarke C. Left triangular ligament lesions are likely hepatic in origin: a systematic review. Br J Radiol 2023; 96:20230231. [PMID: 37747273 PMCID: PMC10646653 DOI: 10.1259/bjr.20230231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2023] [Revised: 07/11/2023] [Accepted: 07/15/2023] [Indexed: 09/26/2023] Open
Abstract
OBJECTIVES The left lobe of the liver is connected to the left hemi-diaphragm by the left triangular ligament (LTL) which crosses the left upper quadrant (LUQ) of the abdomen. LTL lesions are rare and can cause diagnostic confusion. We encountered a hepatocellular carcinoma in the LTL of one patient and given that the LTL has been shown to contain liver tissue in cadaveric studies, we hypothesise that LTL lesions are likely hepatic in origin. The aim of this case series and systematic review was to develop a list of pathological processes encountered at the LTL, which could impact differential diagnoses of lesions within the LUQ. METHODS A case series of two patients are presented. MEDLINE, EMBASE, PubMed, and Google Scholar were searched for studies published until September 2022. All case reports of LTL lesions were eligible for inclusion. PROSPERO registration: CRD42022368250. RESULTS Twelve out of 166 screened studies were included, with 14 cases in total. Seven described mass lesions of hepatic origin, of which three were initially misdiagnosed as gastric tumours leading to considerable diagnostic delay and additional procedures. Seven other cases described postoperative bile leaks from aberrant biliary ducts in the LTL. CONCLUSIONS All mass lesions observed in the LTL were hepatic in origin, and all iatrogenic injuries described resulted in bile leaks. ADVANCES IN KNOWLEDGE To reduce the burden of diagnostic delay and unnecessary procedures, we would suggest that these observations support the addition of hepatic lesions to the differential diagnosis of LUQ lesions.
Collapse
Affiliation(s)
| | - Rahul Munyal
- Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
| | | | - Christopher Clarke
- Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
| |
Collapse
|
9
|
Groot J, MacLellan A, Butler M, Todor E, Zulfiqar M, Thackrah T, Clarke C, Brosnan M, Ainsworth B. The Effectiveness of Fully Automated Digital Interventions in Promoting Mental Well-Being in the General Population: Systematic Review and Meta-Analysis. JMIR Ment Health 2023; 10:e44658. [PMID: 37856172 PMCID: PMC10623223 DOI: 10.2196/44658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Revised: 06/30/2023] [Accepted: 07/07/2023] [Indexed: 10/20/2023] Open
Abstract
BACKGROUND Recent years have highlighted an increasing need to promote mental well-being in the general population. This has led to a rapidly growing market for fully automated digital mental well-being tools. Although many individuals have started using these tools in their daily lives, evidence on the overall effectiveness of digital mental well-being tools is currently lacking. OBJECTIVE This study aims to review the evidence on the effectiveness of fully automated digital interventions in promoting mental well-being in the general population. METHODS Following the preregistration of the systematic review protocol on PROSPERO, searches were carried out in MEDLINE, Web of Science, Cochrane, PsycINFO, PsycEXTRA, Scopus, and ACM Digital (initial searches in February 2022; updated in October 2022). Studies were included if they contained a general population sample and a fully automated digital intervention that exclusively used psychological mental well-being promotion activities. Two reviewers, blinded to each other's decisions, conducted data selection, extraction, and quality assessment of the included studies. Narrative synthesis and a random-effects model of per-protocol data were adopted. RESULTS We included 19 studies that involved 7243 participants. These studies included 24 fully automated digital mental well-being interventions, of which 15 (63%) were included in the meta-analysis. Compared with no intervention, there was a significant small effect of fully automated digital mental well-being interventions on mental well-being in the general population (standardized mean difference 0.19, 95% CI 0.04-0.33; P=.02). Specifically, mindfulness-, acceptance-, commitment-, and compassion-based interventions significantly promoted mental well-being in the general population (P=.006); insufficient evidence was available for positive psychology and cognitive behavioral therapy-based interventions; and contraindications were found for integrative approaches. Overall, there was substantial heterogeneity, which could be partially explained by the intervention duration, comparator, and study outcomes. The risk of bias was high, and confidence in the quality of the evidence was very low (Grading of Recommendations, Assessment, Development, and Evaluations), primarily because of the high rates of study dropout (average 37%; range 0%-85%) and suboptimal intervention adherence (average 40%). CONCLUSIONS This study provides a novel contribution to knowledge regarding the effectiveness, strengths, and weaknesses of fully automated digital mental well-being interventions in the general population. Future research and practice should consider these findings when developing fully automated digital mental well-being tools. In addition, research should aim to investigate positive psychology and cognitive behavioral therapy-based tools as well as develop further strategies to improve adherence and reduce dropout in fully automated digital mental well-being interventions. Finally, it should aim to understand when and for whom these interventions are particularly beneficial. TRIAL REGISTRATION PROSPERO CRD42022310702; https://tinyurl.com/yc7tcwy7.
Collapse
Affiliation(s)
- Julia Groot
- Department of Psychology, University of Bath, Bath, United Kingdom
| | | | - Madelaine Butler
- Department of Psychology, University of Bath, Bath, United Kingdom
| | - Elisa Todor
- Department of Psychology, University of Bath, Bath, United Kingdom
| | - Mahnoor Zulfiqar
- Department of Psychology, University of Bath, Bath, United Kingdom
| | | | - Christopher Clarke
- Department of Computer Science, University of Bath, Bath, United Kingdom
| | - Mark Brosnan
- Centre for Applied Autism Research, Department of Psychology, University of Bath, Bath, United Kingdom
| | - Ben Ainsworth
- School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom
| |
Collapse
|
10
|
Nand KN, Jordan TB, Yuan X, Basore DA, Zagorevski D, Clarke C, Werner G, Hwang JY, Wang H, Chung JJ, McKenna A, Jarvis MD, Singh G, Bystroff C. Bacterial production of recombinant contraceptive vaccine antigen from CatSper displayed on a human papilloma virus-like particle. Vaccine 2023:S0264-410X(23)01114-3. [PMID: 37833124 DOI: 10.1016/j.vaccine.2023.09.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Revised: 09/19/2023] [Accepted: 09/20/2023] [Indexed: 10/15/2023]
Abstract
CatSper is a voltage dependent calcium ion channel present in the principal piece of sperm tail. It plays a crucial role in sperm hyperactivated motility and so in fertilization. Extracellular loops of mouse sperm CatSper were used to develop a vaccine to achieve protection from pregnancy. These loops were inserted at one of the three hypervariable regions of Human Papilloma Virus (HPV) capsid protein (L1). Recombinant vaccines were expressed in E.coli as inclusion body (IB), purified, refolded and assembled into virus-like particles (VLP) in vitro, and adsorbed on alum. Four vaccine candidates were tested in Balb/C mice. All the constructs proved immunogenic, one showed contraceptive efficacy. This recombinant contraceptive vaccine is a non-hormonal intervention and is expected to give long-acting protection from undesired pregnancies.
Collapse
Affiliation(s)
- K N Nand
- Dept of Biological Sciences, Rensselaer Polytechnic Institute, Troy NY, United States
| | - T B Jordan
- Dept of Biological Sciences, Rensselaer Polytechnic Institute, Troy NY, United States
| | - X Yuan
- Dept of Biological Sciences, Rensselaer Polytechnic Institute, Troy NY, United States
| | - D A Basore
- Dept of Biological Sciences, Rensselaer Polytechnic Institute, Troy NY, United States; Department of Health and Natural Science, Mercy College, Dobbs Ferry, NY, United States
| | - D Zagorevski
- Dept of Biological Sciences, Rensselaer Polytechnic Institute, Troy NY, United States
| | - C Clarke
- Dept of Biological Sciences, Rensselaer Polytechnic Institute, Troy NY, United States
| | - G Werner
- Dept of Biological Sciences, Rensselaer Polytechnic Institute, Troy NY, United States
| | - J Y Hwang
- Dept of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, United States
| | - H Wang
- Dept of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, United States
| | - J-J Chung
- Dept of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, United States; Department of Gynecology and Obstetrics, Yale University School of Medicine, New Haven, CT, United States
| | - A McKenna
- Bioresearch Core, Rensselaer Polytechnic Institute, Troy, NY, United States
| | - M D Jarvis
- Bioresearch Core, Rensselaer Polytechnic Institute, Troy, NY, United States
| | - G Singh
- Bioresearch Core, Rensselaer Polytechnic Institute, Troy, NY, United States
| | - C Bystroff
- Dept of Biological Sciences, Rensselaer Polytechnic Institute, Troy NY, United States.
| |
Collapse
|
11
|
Astbury S, Baskar A, Grove JI, Kaye P, Aravinthan AD, James MW, Clarke C, Aithal GP, Venkatachalapathy SV. Next-generation sequencing of pancreatic cyst wall specimens obtained using micro-forceps for improving diagnostic accuracy. Endosc Int Open 2023; 11:E983-E991. [PMID: 37941539 PMCID: PMC10629470 DOI: 10.1055/a-2163-8805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/22/2023] [Accepted: 06/15/2023] [Indexed: 11/10/2023] Open
Abstract
Background and study aims Pancreatic cysts are common incidental findings, with an estimated prevalence of 13% to 15% in imaging done for other reasons. Diagnosis often relies on collection of cyst fluid, but tissue sampling using micro-forceps may allow for a more reliable diagnosis and higher yield of DNA for next-generation sequencing (NGS). The primary aim was to assess the performance of NGS in identifying mucinous cyst. The secondary aims were to assess DNA yield between the cyst fluid and cyst wall tissue, complication rate and performance of conventional investigations. Patients and methods Twenty-four patients referred for endoscopic ultrasound were recruited. Biopsies were taken using micro-forceps and the AmpliSeq Cancer Hotspot panel was used for NGS, a polymerase chain reaction assay targeting several hotspots within 50 genes, including GNAS , KRAS and VHL . Results The concentration of DNA extracted from 24 cyst wall samples was significantly higher than in the nine of 24 available matched cyst fluid samples. The sensitivity, specificity, and diagnostic accuracy of NGS for diagnosing mucinous cyst were 93%, 50% and 84%; for standard of care, they were -66.6%, 50% and 63.1%; and for standard of care with NGS, they were 100%, 50%, and 89.4% respectively. Cyst wall biopsy was able to diagnose 19 of 24 cysts (4 high risk, 7 intraductal papillary mucinous neoplasms, 4 cysts of mucinous origin, and 4 benign). Conclusions NGS data correlate well with histology and may aid in diagnosis and risk stratification of pancreatic cysts. Cyst wall biopsy performs well in diagnosing cysts but was inadequate in five of 24 patients.
Collapse
Affiliation(s)
- Stuart Astbury
- Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK
| | - Aishwarya Baskar
- Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
| | - Jane I. Grove
- Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK
| | - Philip Kaye
- Department of Pathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Aloysious D. Aravinthan
- Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK
| | - Martin W. James
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK
| | - Christopher Clarke
- Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Guruprasad P. Aithal
- Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK
| | - Suresh Vasan Venkatachalapathy
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK
| |
Collapse
|
12
|
Ponce SEB, Small CJ, Ahmad T, Patel K, Tsai S, Kamgar M, George B, Kharofa JR, Saeed H, Dua KS, Clarke C, Aldakkak M, Evans DB, Christians K, Paulson ES, de Choudens SO, Erickson BA, Hall WA. Patterns of Locoregional Pancreatic Cancer Recurrence after Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes. Int J Radiat Oncol Biol Phys 2023; 117:e284-e285. [PMID: 37785058 DOI: 10.1016/j.ijrobp.2023.06.1270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Neoadjuvant treatment for patients with localized pancreatic adenocarcinoma (PDAC) has improved survival duration. As survival increases, local disease control becomes even more important. We sought to understand the patterns of locoregional recurrence following total neoadjuvant therapy (TNT) and determine the impact of treatment volumes on recurrence. MATERIALS/METHODS Patients with PDAC managed with neoadjuvant chemotherapy and chemoradiation (TNT) followed by surgery who developed an isolated locoregional or simultaneously locoregional and distant recurrence were identified. Locoregional recurrences were individually contoured utilizing commercially available software. When available, original neoadjuvant dose distributions were registered to the scans on which the locoregional recurrences were contoured. Recurrences where then classified as in-field (> 95% of prescription dose), marginal (50-95% of prescription dose), or out of field (< 50% of prescription dose). Target volumes were created using four commonly utilized PDAC contouring guidelines to characterize the relationship of the local recurrence to the RT dose distribution. RESULTS Of 474 patients treated with TNT and surgery, 80 (17%) patients developed a locoregional recurrence with or without distant recurrence, visible on diagnostic imaging. Of the 80 patients, 56 (70%) had tumors in the pancreatic head; 46 (57.5%) were borderline resectable, 23 (28.8%) locally advanced, and 11 (13.6%) resectable. The most common initial neoadjuvant therapies were FOLFIRINOX (57.5%) and gemcitabine/nab-paclitaxel (18.8%). Chemoradiation included concurrent gemcitabine (47.5%) or 5-fluorouracil (26.3%). RT dose distributions were available for 38 patients; 22 (57.9%) had in-field failures, 9 (23.7%) marginal failures, and 7 (18.4%) out of field failures. Each published contouring atlas covered a relatively low percentage of recurrences, which are summarized in Table 1. Regions at particularly high likelihood of recurrence that were under covered on existing atlases included: aortic-diaphragmic junction, retro-pancreatic duodenal nodal basin, and the region to the right of the superior mesenteric artery (SMA). CONCLUSION We present the largest series (to our knowledge) of mapped locoregional recurrences for patients being treated with TNT in PDAC. These recurrences differ substantially from established atlases and highlight anatomical regions of highest priority for RT coverage. A novel visual contouring volume highlighting these regions will be presented which will strive to advance the use of RT in the TNT setting.
Collapse
Affiliation(s)
- S E Beltran Ponce
- Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - C J Small
- Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - T Ahmad
- Medical College of Wisconsin, Milwaukee, WI
| | - K Patel
- Medical College of Wisconsin, Milwaukee, WI
| | - S Tsai
- Department of Surgery, Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - M Kamgar
- Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - B George
- Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - J R Kharofa
- University of Cincinnati, Department of Radiation Oncology, University of Cincinnati Cancer Center, Cincinnati, OH
| | - H Saeed
- Lynn Cancer Institute, Boca Raton Regional Hospital, Baptist Health South Florida, Boca Raton, FL
| | - K S Dua
- Department of Gastroenterology, Medical College of Wisconsin, Milwaukee, WI
| | - C Clarke
- Department of Surgery, Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - M Aldakkak
- Department of Surgery, Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - D B Evans
- Department of Surgery, Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - K Christians
- Department of Surgery, Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - E S Paulson
- Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - S Ortiz de Choudens
- Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI; Department of Radiation Oncology, Froedtert & the Medical College of Wisconsin, Milwaukee, WI
| | - B A Erickson
- Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
| | - W A Hall
- Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
| |
Collapse
|
13
|
Barnett R, Clarke C, Sengupta R, Rouse PC. Protocol for a systematic literature review of smartphone apps to support the self-management of rheumatic and musculoskeletal diseases: development strategies, theoretical underpinnings and barriers to engagement. Syst Rev 2023; 12:129. [PMID: 37516896 PMCID: PMC10385957 DOI: 10.1186/s13643-023-02276-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Accepted: 06/18/2023] [Indexed: 07/31/2023] Open
Abstract
BACKGROUND Rheumatic and musculoskeletal diseases (RMDs) cause significant burden to the individual and society, requiring lifelong management and specialist healthcare resource use. Costing over 200 billion euros per year in Europe, RMDs are the most expensive of all diseases for European healthcare systems. The incidence and burden of RMDs are projected to rise with the ageing global population and increase in sedentary, obesogenic lifestyles. In parallel, there is a global crisis in the rheumatology workforce, whereby capacity to deliver specialist care is being exceeded by demand. Pervasive, scalable mobile health technologies, such as apps, are being developed to support the self-management of RMDs and reduce pressure on healthcare services. However, it is unknown whether these apps are informed by theory or their use supported by an appropriate evidence base. The purpose of this review is therefore to provide a comprehensive overview of the development strategies, interventional components and theoretical underpinnings of existing smartphone apps, designed to support the self-management of RMDs. METHODS Searches will be conducted within PubMed, Scopus, Web of Science, Embase, MEDLINE and PsycINFO. Reference lists and citing articles of the included studies will be searched. Identified publications will be screened for eligibility by two independent reviewers. Any discrepancies between reviewers will be resolved by consensus, with input from a third reviewer if required. Data will be extracted on study designs, methods, populations, setting, utilised theoretical frameworks, intervention components, behaviour change techniques, methods to evaluate effectiveness and barriers/facilitators to intervention engagement. Exploratory outcomes include reported effectiveness, acceptability and usability. A systematic, narrative synthesis of evidence will be presented. If appropriate (depending on quality and pool of evidence identified), qualitative meta-summary techniques will be used to combine and summarise qualitative findings regarding barriers/facilitators to intervention engagement. DISCUSSION The results of this systematic literature review will provide insights for healthcare professionals, researchers, app designers and policy makers, to inform future development and implementation of smartphone apps to support self-management of RMDs. Evidence gaps for future research will be identified. Findings will be disseminated through a final manuscript/publication of results and via a conference abstract, patient organisations and social media. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42022359704.
Collapse
Affiliation(s)
- Rosemarie Barnett
- Department for Health, University of Bath, Bath, UK.
- Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
| | | | - Raj Sengupta
- Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK
| | | |
Collapse
|
14
|
Dale MacLaine T, Baker O, Omura M, Clarke C, Howell SJ, Burke D. Prospective comparison of two methods for assessing sarcopenia and interobserver agreement on retrospective CT images. Postgrad Med J 2023; 99:455-462. [PMID: 37294725 DOI: 10.1136/postgradmedj-2021-141301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Accepted: 05/14/2022] [Indexed: 11/04/2022]
Abstract
PURPOSE OF THE STUDY To compare the relationships between two CT derived sarcopenia assessment methods, and compare their relationship with inter-rater and intrarater validations and colorectal surgical outcomes. STUDY DESIGN 157 CT scans were identified across Leeds Teaching Hospitals National Health Service Trust for patients undergoing colorectal cancer surgery. 107 had body mass index data available, required to determine sarcopenia status. This work explores the relationship between sarcopenia, as measured by both total cross sectional-area (TCSA) and psoas-area (PA) and surgical outcomes. All images were assessed for inter-rater and intrarater variability for both TCSA and PA methods of sarcopenia identification. The raters included a radiologist, an anatomist and two medical students. RESULTS Prevalence of sarcopenia was different when measured by PA (12.2%-22.4%) in comparison to TCSA (60.8%-70.1%). Strong correlation exists between muscle areas in both TCSA and PA measures, however, there were significant differences between methods after the application of method-specific cut-offs. There was substantial agreement for both intrarater and inter-rater comparisons for both TCSA and PA sarcopenia measures. Outcome data were available for 99/107 patients. Both TCSA and PA have poor association with adverse outcomes following colorectal surgery. CONCLUSIONS CT-determined sarcopenia can be identified by junior clinicians, those with anatomical understanding and radiologists. Our study identified sarcopenia to have a poor association with adverse surgical outcomes in a colorectal population. Published methods of identifying sarcopenia are not translatable to all clinical populations. Currently available cut-offs require refinement for potential confounding factors, to provide more valuable clinical information. WHAT IS ALREADY KNOWN ON THIS TOPIC? WHAT DOES THIS STUDY ADD? HOW MIGHT THIS STUDY AFFECT RESEARCH, PRACTICE OR POLICY?
Collapse
Affiliation(s)
| | - Oliver Baker
- John Goligher Colorectal Surgery Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - Miyuki Omura
- John Goligher Colorectal Surgery Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - Christopher Clarke
- GI & HPB Imaging and Intervention, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Simon J Howell
- Leeds Institute of Medical Research, University of Leeds, Leeds, UK
| | - Dermot Burke
- John Goligher Colorectal Surgery Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| |
Collapse
|
15
|
Bonica J, Clarke C, Obeid LM, Luberto C, Hannun YA. Upregulation of sphingosine kinase 1 in response to doxorubicin generates an angiogenic response via stabilization of Snail. FASEB J 2023; 37:e22787. [PMID: 36723905 PMCID: PMC9979566 DOI: 10.1096/fj.202201066r] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2022] [Revised: 12/27/2022] [Accepted: 01/10/2023] [Indexed: 02/02/2023]
Abstract
Sphingosine kinase 1 (SK1) converts the pro-death lipid sphingosine to the pro-survival sphingosine-1-phosphate (S1P) and is upregulated in several cancers. DNA damaging agents, such as the chemotherapeutic doxorubicin (Dox), have been shown to degrade SK1 protein in cancer cells, a process dependent on wild-type p53. As mutations in p53 are very common across several types of cancer, we evaluated the effects of Dox on SK1 in p53 mutant cancer cells. In the p53 mutant breast cancer cell line MDA-MB-231, we show that Dox treatment significantly increases SK1 protein and S1P. Using MDA-MB-231 cells with CRISPR-mediated knockout of SK1 or the selective SK1 inhibitor PF-543, we implicated SK1 in both Dox-induced migration and in a newly uncovered proangiogenic program induced by Dox. Mechanistically, inhibition of SK1 suppressed the induction of the cytokine BMP4 and of the EMT transcription factor Snail in response to Dox. Interestingly, induction of BMP4 by SK1 increased Snail levels following Dox treatment by stabilizing Snail protein. Furthermore, we found that SK1 was required for Dox-induced p38 MAP kinase phosphorylation and that active p38 MAPK in turn upregulated BMP4 and Snail, positioning p38 downstream of SK1 and upstream of BMP4/Snail. Modulating production of S1P by inhibition of de novo sphingolipid synthesis or knockdown of the S1P-degrading enzyme S1P lyase identified S1P as the sphingolipid activator of p38 in this model. This work establishes a novel angiogenic pathway in response to a commonly utilized chemotherapeutic and highlights the potential of SK1 as a secondary drug target for patients with p53 mutant cancer.
Collapse
Affiliation(s)
- Joseph Bonica
- Department of Pharmacology, Stony Brook University, Stony Brook, NY 11794
- Cancer Center, Stony Brook University, Stony Brook, NY 11794
| | | | - Lina M. Obeid
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794
- Cancer Center, Stony Brook University, Stony Brook, NY 11794
- Northport Veterans Affairs Medical Center, Northport, NY, USA
| | - Chiara Luberto
- Department of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794
- Cancer Center, Stony Brook University, Stony Brook, NY 11794
| | - Yusuf A. Hannun
- Department of Pharmacology, Stony Brook University, Stony Brook, NY 11794
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794
- Cancer Center, Stony Brook University, Stony Brook, NY 11794
- Northport Veterans Affairs Medical Center, Northport, NY, USA
- Departments of Biochemistry and Pathology, Stony Brook University, Stony Brook, NY 11794
| |
Collapse
|
16
|
Gualtieri P, Al-Wadart M, De Santis GL, Alwadart N, Della Morte D, Clarke C, Best T, Salimei C, Bigioni G, Cianci R, De Lorenzo A, Di Renzo L. The role of MTHFR polymorphisms in the risk of lipedema. Eur Rev Med Pharmacol Sci 2023; 27:1625-1632. [PMID: 36876707 DOI: 10.26355/eurrev_202302_31407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 03/07/2023]
Abstract
OBJECTIVE This study examines the role of MTHFR gene polymorphism (rs1801133) in women with lipedema (LIPPY) body composition parameters compared to a control group (CTRL). SUBJECTS AND METHODS We carried out a study on a sample of 45 LIPPY and 50 women as a CTRL. Body composition parameters were examined by Dual-energy X-ray Absorptiometry (DXA). A genetic test was performed for the MTHFR polymorphism (rs1801133, 677C>T) using a saliva sample for LIPPY and CTRL groups. Mann-Whitney tests evaluated statistically significant differences between four groups (carriers and non-carriers of the MTHFR polymorphism for LIPPY and CTRL groups) on anthropometric/body composition parameters to identify patterns. RESULTS LIPPY showed significantly higher (p<0.05) anthropometric parameters (weight, BMI, waist, abdominal, hip circumferences) and lower waist/hip ratio (p<0.05) compared to the CTRL group. The association between the polymorphism alleles related to the rs1801133 MTHFR gene and the body composition values LIPPY carriers (+) showed an increase in fat tissue of legs and fat region of legs percentage, arm's fat mass (g), leg's fat mass (g), and leg's lean mass (g) (p<0.05) compared to CTRL (+). Lean/fat arms and lean/fat legs were lower (p<0.05) in LIPPY (+) than in CTRL (+). In the LIPPY (+), the risk of developing the lipedema disease was 2.85 times higher (OR=2.85; p<0.05; 95% confidence interval = 0.842-8.625) with respect to LIPPY (-) and CTRL. CONCLUSIONS The presence or absence of MTHFR polymorphism offers predictive parameters that could better characterize women with lipedema based on the association between body composition and MTHFR presence.
Collapse
Affiliation(s)
- P Gualtieri
- Department of Biomedicine and Prevention, Section of Clinical Nutrition and Nutrigenomics, University of Tor Vergata, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Scott RA, Cross TJS, Clarke C, Khan SA, Ryder SD, Franklin J, Aravinthan AD. Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance. J Hepatocell Carcinoma 2023; 10:725-731. [PMID: 37152438 PMCID: PMC10155710 DOI: 10.2147/jhc.s403702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Accepted: 03/14/2023] [Indexed: 05/09/2023] Open
Abstract
Background & Aim HCC has significantly improved outcomes when detected early. Guidelines recommend biannual surveillance with ultrasound (US) and/or AFP in at-risk individuals. This survey aimed to describe HCC surveillance adherence/practices amongst the NHS hospitals in the UK. Methods An electronic survey was sent to 79 NHS hospitals via the British Association for the Study of the Liver distribution list. The responses were captured from July 2021 to January 2022. Centres were divided into hepato-pancreato-biliary (HPB) and non-HPB centres, depending on whether the hospital undertakes major liver surgeries. Results A total of 39 (49.3%) centres responded: 15 HPB and 24 non-HPB centres from across the UK. HCC surveillance eligibility criteria were universally applied, but heterogeneous approaches occur outside these criteria. Eighty per cent of patients undergoing surveillance were estimated to have cirrhosis. Eighty-five per cent of centres do 6-monthly US and AFP requested by clinicians and liver clinical nurse specialists. Compliance was estimated at 80% but not routinely audited. In most centres, general sonographers and/or radiologists perform surveillance US scans without a standard reporting template, although structured reporting was viewed as desirable by the majority. Poor views on US are approached heterogeneously, with patients variably offered ongoing US, CT, or MRI with different protocols. Conclusion Most responding NHS hospitals follow 6-monthly HCC surveillance guidance. Data recording is variable, with limited routine data collection regarding compliance, yield, and quality. Surveillance US is mostly performed by non-HPB specialists without standardised reporting. There is an inconsistent approach to poor views with US surveillance. Even in a universal healthcare system such as NHS, which is free at the point of care, delivery of HCC surveillance has not improved over the last decade and remains variable.
Collapse
Affiliation(s)
- Robert A Scott
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK
- Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
| | - Timothy J S Cross
- Royal Liverpool and Broadgreen University Hospital NHS Trust, Liverpool, UK
| | - Christopher Clarke
- Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Shahid A Khan
- Division of Digestive Diseases, Imperial College London, London, UK
| | - Stephen D Ryder
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK
| | - James Franklin
- Institute of Medical Imaging and Visualisation, Bournemouth University, BournemouthUK
- Correspondence: James Franklin, Institute of Medical Imaging and Visualisation, Bournemouth University, Bournemouth Gateway Building, St Paul's Lane, Bournemouth, BH8 8GP, UK, Email
| | - Aloysious D Aravinthan
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK
- Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
- Aloysious D Aravinthan, Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK, Email
| |
Collapse
|
18
|
Cameron D, Sharma V, Biswas C, Clarke C, Chandiwana D, Pathak P. Cost-effectiveness of first-line ribociclib use vs palbociclib in the treatment of postmenopausal women with HR+/HER2− advanced breast cancer: analysis based on final OS results of MONALEESA-2 and PALOMA-2. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)01530-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
19
|
Murphy F, O'Reilly S, Clarke C, Kennelly S. 32 HOLISTIC PERSON-CENTRED CARE FOR PEOPLE LIVING WITH DEMENTIA AND CO EXISTING MENTAL HEALTH ILLNESSES: A CASE FOR INTEGRATION. Age Ageing 2022. [PMCID: PMC9620330 DOI: 10.1093/ageing/afac218.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Background 65,000 people live with dementia in Ireland, many have co-existing or emerging mental health illnesses and non-cognitive symptoms. During the COVID-19 pandemic there was a need to provide innovative solutions to service provision. As Medicine for the Elderly (MEDEL) and Psychiatry of Later Life (PLL) were established stand-alone services, there was no formalised working relationship, resulting in an overlap of cases and disparity in service provision. Methods A description of three cases to illustrate the joint working interface with MEDEL and PLL. These cases highlight their complex care needs and the speciality input required by both services within a shared catchment area. The age range was 78-88 years. All presented with at least two medical co-morbidities, including vascular risk factors and delirium. Each had at least one mental health illness including new onset psychotic and mood disorders. Sharing of resources including diagnostic services, nursing, medical, occupational therapy, physiotherapy and social work facilitated cost effective holistic care. Results Given the existing structures of MEDEL and PLL, it was possible to link with community partners attached to each service, allowing domiciliary visits for crisis intervention and best use of expertise from both disciplines. This resulted in the provision of timely patient centred care, reduced polypharmacy through a unified pharmacological approach, enhanced communication, shared learning and cost effectiveness. Care that is in the right place at the right time, in line with Sláinte Care, allowed timely access to diagnostics, improved care outcomes and a cohesive response. Conclusion This cohort present with complex care needs. An integrated approach enables patients to receive holistic care without duplication of resources or disparity of treatment and care options. Going forward this should involve a fully integrated memory service, with shared governance.
Collapse
Affiliation(s)
- F Murphy
- Connolly Hospital , Dublin, Ireland
| | | | - C Clarke
- Dublin North City and County Mental Health Services , Dublin, Ireland
| | | |
Collapse
|
20
|
Giannotti E, Jethwa K, Closs S, Sun R, Bhatti H, James J, Clarke C. Promoting simulation-based training in radiology: a homemade phantom for the practice of ultrasound-guided procedures. Br J Radiol 2022; 95:20220354. [PMID: 35856798 PMCID: PMC10996965 DOI: 10.1259/bjr.20220354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2022] [Revised: 07/06/2022] [Accepted: 07/12/2022] [Indexed: 11/05/2022] Open
Abstract
OBJECTIVE Ultrasound-guided intervention is an essential skill for many radiologists and critical for accurate diagnosis and treatment in many radiology subspecialties. Simulation using phantoms have demonstrated statistically significant benefits for trainees within the literature. We propose a novel phantom model which the authors feel is ideal for training clinical radiology trainees in the performance of ultrasound-guided procedures. METHODS The recipe to prepare a homemade phantom is described. Results of a local survey from trainees preparing and using the phantom are also presented. RESULTS This realistic training simulation model can be adapted to suit a variety of biopsy devices and procedures including soft tissue biopsy and cyst aspiration. The phantom mimics the sonographic appearances of soft tissue and biopsy targets can be concealed within. The phantom was easily prepared by 22 trainees (Likert score 4.5) and it functioned well (Likert score of 4.7). CONCLUSION In summary, our phantom model is ideal for training clinical radiology trainees in the performance of ultrasound-guided core biopsy. The availability and low cost of the model, combined with the ease of preparation and reproducibility, make this an efficient and effective addition to the training process. ADVANCES IN KNOWLEDGE A low cost easily handmade phantom recipe is described that could be easily implemented in training schemes.
Collapse
Affiliation(s)
- Elisabetta Giannotti
- Nottingham Breast Institute, Nottingham University Hospitals
NHS Trust, Nottingham City Hospital, Hucknall Road,
Nottingham, UK
| | - Ketan Jethwa
- University Hospitals of Derby and Burton NHS Foundation Trust,
Royal Derby Hospital, Uttoxeter New Road,
Derby, UK
| | - Samantha Closs
- Nottingham Breast Institute, Nottingham University Hospitals
NHS Trust, Nottingham City Hospital, Hucknall Road,
Nottingham, UK
| | - Rachel Sun
- Nottingham Breast Institute, Nottingham University Hospitals
NHS Trust, Nottingham City Hospital, Hucknall Road,
Nottingham, UK
| | - Hamnah Bhatti
- Department of Clinical Radiology, Nottingham University
Hospitals NHS Trust, Queens Medical Centre, Derby Road,
Nottingham, UK
| | - Jonathan James
- Nottingham Breast Institute, Nottingham University Hospitals
NHS Trust, Nottingham City Hospital, Hucknall Road,
Nottingham, UK
| | - Christopher Clarke
- Department of Clinical Radiology, Nottingham University
Hospitals NHS Trust, Queens Medical Centre, Derby Road,
Nottingham, UK
| |
Collapse
|
21
|
Adhikari D, Albataineh H, Androic D, Aniol KA, Armstrong DS, Averett T, Ayerbe Gayoso C, Barcus SK, Bellini V, Beminiwattha RS, Benesch JF, Bhatt H, Bhatta Pathak D, Bhetuwal D, Blaikie B, Boyd J, Campagna Q, Camsonne A, Cates GD, Chen Y, Clarke C, Cornejo JC, Covrig Dusa S, Dalton MM, Datta P, Deshpande A, Dutta D, Feldman C, Fuchey E, Gal C, Gaskell D, Gautam T, Gericke M, Ghosh C, Halilovic I, Hansen JO, Hassan O, Hauenstein F, Henry W, Horowitz CJ, Jantzi C, Jian S, Johnston S, Jones DC, Kakkar S, Katugampola S, Keppel C, King PM, King DE, Kumar KS, Kutz T, Lashley-Colthirst N, Leverick G, Liu H, Liyanage N, Mammei J, Mammei R, McCaughan M, McNulty D, Meekins D, Metts C, Michaels R, Mihovilovic M, Mondal MM, Napolitano J, Narayan A, Nikolaev D, Owen V, Palatchi C, Pan J, Pandey B, Park S, Paschke KD, Petrusky M, Pitt ML, Premathilake S, Quinn B, Radloff R, Rahman S, Rashad MNH, Rathnayake A, Reed BT, Reimer PE, Richards R, Riordan S, Roblin YR, Seeds S, Shahinyan A, Souder P, Thiel M, Tian Y, Urciuoli GM, Wertz EW, Wojtsekhowski B, Yale B, Ye T, Yoon A, Xiong W, Zec A, Zhang W, Zhang J, Zheng X. Precision Determination of the Neutral Weak Form Factor of ^{48}Ca. Phys Rev Lett 2022; 129:042501. [PMID: 35939025 DOI: 10.1103/physrevlett.129.042501] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Revised: 06/15/2022] [Accepted: 06/16/2022] [Indexed: 06/15/2023]
Abstract
We report a precise measurement of the parity-violating (PV) asymmetry A_{PV} in the elastic scattering of longitudinally polarized electrons from ^{48}Ca. We measure A_{PV}=2668±106(stat)±40(syst) parts per billion, leading to an extraction of the neutral weak form factor F_{W}(q=0.8733 fm^{-1})=0.1304±0.0052(stat)±0.0020(syst) and the charge minus the weak form factor F_{ch}-F_{W}=0.0277±0.0055. The resulting neutron skin thickness R_{n}-R_{p}=0.121±0.026(exp)±0.024(model) fm is relatively thin yet consistent with many model calculations. The combined CREX and PREX results will have implications for future energy density functional calculations and on the density dependence of the symmetry energy of nuclear matter.
Collapse
Affiliation(s)
- D Adhikari
- Idaho State University, Pocatello, Idaho 83209, USA
| | - H Albataineh
- Texas A & M University-Kingsville, Kingsville, Texas 78363, USA
| | - D Androic
- University of Zagreb, Faculty of Science, Zagreb, HR 10002, Croatia
| | - K A Aniol
- California State University, Los Angeles, Los Angeles, California 90032, USA
| | | | - T Averett
- William and Mary, Williamsburg, Virginia 23185, USA
| | | | - S K Barcus
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Bellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Catania, 95123 Catania, Italy
| | | | - J F Benesch
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Bhatt
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | | | - D Bhetuwal
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - B Blaikie
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - J Boyd
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - Q Campagna
- William and Mary, Williamsburg, Virginia 23185, USA
| | - A Camsonne
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - G D Cates
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - Y Chen
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - C Clarke
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - J C Cornejo
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - S Covrig Dusa
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M M Dalton
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Datta
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Deshpande
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- Center for Frontiers in Nuclear Science, Stony Brook, New York 11794, USA
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - D Dutta
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - C Feldman
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- Institute for Advanced Computational Science, Stony Brook, New York 11794, USA
| | - E Fuchey
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - C Gal
- Mississippi State University, Mississippi State, Mississippi 39762, USA
- University of Virginia, Charlottesville, Virginia 22904, USA
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- Center for Frontiers in Nuclear Science, Stony Brook, New York 11794, USA
| | - D Gaskell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T Gautam
- Hampton University, Hampton, Virginia 23668, USA
| | - M Gericke
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - C Ghosh
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - I Halilovic
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - J-O Hansen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - O Hassan
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - F Hauenstein
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Henry
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - C J Horowitz
- Indiana University, Bloomington, Indiana 47405, USA
| | - C Jantzi
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - S Jian
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - S Johnston
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - D C Jones
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Kakkar
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - S Katugampola
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - C Keppel
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P M King
- Ohio University, Athens, Ohio 45701, USA
| | - D E King
- Temple University, Philadelphia, Pennsylvania 19122, USA
- Syracuse University, Syracuse, New York 13244, USA
| | - K S Kumar
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - T Kutz
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | | | - G Leverick
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - H Liu
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - N Liyanage
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - J Mammei
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - R Mammei
- University of Winnipeg, Winnipeg, Manitoba R3B2E9, Canada
| | - M McCaughan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D McNulty
- Idaho State University, Pocatello, Idaho 83209, USA
| | - D Meekins
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Metts
- William and Mary, Williamsburg, Virginia 23185, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Mihovilovic
- Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia
- Faculty of Mathematics and Physics, University of Ljubljana, SI-1000 Ljubljana, Slovenia
| | - M M Mondal
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- Center for Frontiers in Nuclear Science, Stony Brook, New York 11794, USA
| | - J Napolitano
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - A Narayan
- Veer Kunwar Singh University, Ara, Bihar 802301, India
| | - D Nikolaev
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - V Owen
- William and Mary, Williamsburg, Virginia 23185, USA
| | - C Palatchi
- University of Virginia, Charlottesville, Virginia 22904, USA
- Center for Frontiers in Nuclear Science, Stony Brook, New York 11794, USA
| | - J Pan
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - B Pandey
- Hampton University, Hampton, Virginia 23668, USA
| | - S Park
- Mississippi State University, Mississippi State, Mississippi 39762, USA
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - K D Paschke
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - M Petrusky
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - M L Pitt
- Virginia Tech, Blacksburg, Virginia 24061, USA
| | - S Premathilake
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - B Quinn
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - R Radloff
- Ohio University, Athens, Ohio 45701, USA
| | - S Rahman
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - M N H Rashad
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - A Rathnayake
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - B T Reed
- Indiana University, Bloomington, Indiana 47405, USA
| | - P E Reimer
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - R Richards
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - S Riordan
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - Y R Roblin
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Seeds
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Shahinyan
- A. I. Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan 0036, Armenia
| | - P Souder
- Syracuse University, Syracuse, New York 13244, USA
| | - M Thiel
- Institut für Kernphysik, Johannes Gutenberg-Universität, Mainz 55122, Germany
| | - Y Tian
- Syracuse University, Syracuse, New York 13244, USA
| | | | - E W Wertz
- William and Mary, Williamsburg, Virginia 23185, USA
| | - B Wojtsekhowski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Yale
- William and Mary, Williamsburg, Virginia 23185, USA
| | - T Ye
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - A Yoon
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - W Xiong
- Syracuse University, Syracuse, New York 13244, USA
- Shandong University, Qingdao, Shandong 266237, China
| | - A Zec
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - W Zhang
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - J Zhang
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- Center for Frontiers in Nuclear Science, Stony Brook, New York 11794, USA
- Shandong University, Qingdao, Shandong 266237, China
| | - X Zheng
- University of Virginia, Charlottesville, Virginia 22904, USA
| |
Collapse
|
22
|
Arm R, Shahidi A, Clarke C, Alabraba E. Synthesis and characterisation of a cancerous liver for presurgical planning and training applications. BMJ Open Gastroenterol 2022; 9:e000909. [PMID: 35853677 PMCID: PMC9301799 DOI: 10.1136/bmjgast-2022-000909] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/10/2022] [Accepted: 06/27/2022] [Indexed: 11/29/2022] Open
Abstract
OBJECTIVES Oncology surgeons use animals and cadavers in training because of a lack of alternatives. The aim of this work was to develop a design methodology to create synthetic liver models familiar to surgeons, and to help plan, teach and rehearse patient-specific cancerous liver resection surgery. DESIGN Synthetic gels were selected and processed to recreate accurate anthropomorphic qualities. Organic and synthetic materials were mechanically tested with the same equipment and standards to determine physical properties like hardness, elastic modulus and viscoelasticity. Collected data were compared with published data on the human liver. Patient-specific CT data were segmented and reconstructed and additive manufactured models were made of the liver vasculature, parenchyma and lesion. Using toolmaking and dissolvable scaffolds, models were transformed into tactile duplicates that could mimic liver tissue behaviour. RESULTS Porcine liver tissue hardness was found to be 23 H00 (±0.1) and synthetic liver was 10 H00 (±2.3), while human parenchyma was reported as 15.06 H00 (±2.64). Average elastic Young's modulus of human liver was reported as 0.012 MPa, and synthetic liver was 0.012 MPa, but warmed porcine parenchyma was 0.28 MPa. The final liver model demonstrated a time-dependant viscoelastic response to cyclic loading. CONCLUSION Synthetic liver was better than porcine liver at recreating the mechanical properties of living human liver. Warmed porcine liver was more brittle, less extensible and stiffer than both human and synthetic tissues. Qualitative surgical assessment of the model by a consultant liver surgeon showed vasculature was explorable and that bimanual palpation, organ delivery, transposition and organ slumping were analogous to human liver behaviour.
Collapse
Affiliation(s)
- Richard Arm
- School of Art and Design, Nottingham Trent University City Campus, Nottingham, UK
| | - Arash Shahidi
- School of Art and Design, Nottingham Trent University City Campus, Nottingham, UK
| | - Christopher Clarke
- Department of Radiology, Queens Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Edward Alabraba
- Department of Hepatobiliary and Pancreatic Surgery, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK
| |
Collapse
|
23
|
Dale MacLaine T, Baker O, Omura M, Clarke C, Howell SJ, Burke D. Prospective comparison of two methods for assessing sarcopenia and interobserver agreement on retrospective CT images. Postgrad Med J 2022:7127881. [PMID: 37073570 DOI: 10.1136/postmj/postgradmedj-2021-141301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Accepted: 05/14/2022] [Indexed: 04/20/2023]
Abstract
PURPOSE OF THE STUDY To compare the relationships between two CT derived sarcopenia assessment methods, and compare their relationship with inter-rater and intrarater validations and colorectal surgical outcomes. STUDY DESIGN 157 CT scans were identified across Leeds Teaching Hospitals National Health Service Trust for patients undergoing colorectal cancer surgery. 107 had body mass index data available, required to determine sarcopenia status. This work explores the relationship between sarcopenia, as measured by both total cross sectional-area (TCSA) and psoas-area (PA) and surgical outcomes. All images were assessed for inter-rater and intrarater variability for both TCSA and PA methods of sarcopenia identification. The raters included a radiologist, an anatomist and two medical students. RESULTS Prevalence of sarcopenia was different when measured by PA (12.2%-22.4%) in comparison to TCSA (60.8%-70.1%). Strong correlation exists between muscle areas in both TCSA and PA measures, however, there were significant differences between methods after the application of method-specific cut-offs. There was substantial agreement for both intrarater and inter-rater comparisons for both TCSA and PA sarcopenia measures. Outcome data were available for 99/107 patients. Both TCSA and PA have poor association with adverse outcomes following colorectal surgery. CONCLUSIONS CT-determined sarcopenia can be identified by junior clinicians, those with anatomical understanding and radiologists. Our study identified sarcopenia to have a poor association with adverse surgical outcomes in a colorectal population. Published methods of identifying sarcopenia are not translatable to all clinical populations. Currently available cut-offs require refinement for potential confounding factors, to provide more valuable clinical information. WHAT IS ALREADY KNOWN ON THIS TOPIC? WHAT DOES THIS STUDY ADD? HOW MIGHT THIS STUDY AFFECT RESEARCH, PRACTICE OR POLICY?
Collapse
Affiliation(s)
| | - Oliver Baker
- John Goligher Colorectal Surgery Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - Miyuki Omura
- John Goligher Colorectal Surgery Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - Christopher Clarke
- GI & HPB Imaging and Intervention, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Simon J Howell
- Leeds Institute of Medical Research, University of Leeds, Leeds, UK
| | - Dermot Burke
- John Goligher Colorectal Surgery Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| |
Collapse
|
24
|
Shaban N, Hoad CL, Naim I, Alshammari M, Radford SJ, Clarke C, Marciani L, Moran G. Imaging in inflammatory bowel disease: current and future perspectives. Frontline Gastroenterol 2022; 13:e28-e34. [PMID: 35812031 PMCID: PMC9234729 DOI: 10.1136/flgastro-2022-102117] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Accepted: 05/22/2022] [Indexed: 02/04/2023] Open
Abstract
The use of cross-sectional imaging and ultrasonography has long complemented endoscopic assessment of inflammatory bowel disease (IBD). Clinical symptoms alone are often not enough to assess disease activity, so a reliance on non-invasive techniques is essential. In this paper, we aim to examine the current use of radiological modalities in aiding the management of patients with IBD. We focus on the various sections of the gastrointestinal tract and how different modalities can aid in assessing current disease state and response to treatments. We also have a look at how newer sequences in cross-sectional imaging and ultrasonography can allow for better differentiation of disease activity (ie, fibrotic vs inflammatory) as well improve evaluation of small bowel, colonic and perianal disease. Furthermore, we examine how advanced image processing has the potential to allow radiology to be a surrogate for biomarkers. An example of this is explored when reviewing the ability of MR sequences to quantify visceral fat, which potentially plays a role in determining disease activity in Crohn's disease. Lastly, we look into the expected role for artificial intelligence to be used as an adjunct to radiology to better improve IBD evaluation.
Collapse
Affiliation(s)
- Nader Shaban
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Caroline L Hoad
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK,NIHR Nottingham Biomedical Research Centre, University of Nottingham University Park Campus, Nottingham, UK
| | - Iyad Naim
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK,NIHR Nottingham Biomedical Research Centre, University of Nottingham University Park Campus, Nottingham, UK
| | - Meshari Alshammari
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK,NIHR Nottingham Biomedical Research Centre, University of Nottingham University Park Campus, Nottingham, UK
| | - Shellie Jean Radford
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK,NIHR Nottingham Biomedical Research Centre, University of Nottingham University Park Campus, Nottingham, UK
| | - Christopher Clarke
- Department of Radiology, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Luca Marciani
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK,NIHR Nottingham Biomedical Research Centre, University of Nottingham University Park Campus, Nottingham, UK
| | - Gordon Moran
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK,NIHR Nottingham Biomedical Research Centre, University of Nottingham University Park Campus, Nottingham, UK
| |
Collapse
|
25
|
Adhikari D, Albataineh H, Androic D, Aniol K, Armstrong DS, Averett T, Ayerbe Gayoso C, Barcus S, Bellini V, Beminiwattha RS, Benesch JF, Bhatt H, Bhatta Pathak D, Bhetuwal D, Blaikie B, Boyd J, Campagna Q, Camsonne A, Cates GD, Chen Y, Clarke C, Cornejo JC, Covrig Dusa S, Dalton MM, Datta P, Deshpande A, Dutta D, Feldman C, Fuchey E, Gal C, Gaskell D, Gautam T, Gericke M, Ghosh C, Halilovic I, Hansen JO, Hauenstein F, Henry W, Horowitz CJ, Jantzi C, Jian S, Johnston S, Jones DC, Karki B, Kakkar S, Katugampola S, Keppel CE, King PM, King DE, Knauss M, Kumar KS, Kutz T, Lashley-Colthirst N, Leverick G, Liu H, Liyange N, Malace S, Mammei J, Mammei R, McCaughan M, McNulty D, Meekins D, Metts C, Michaels R, Mihovilovic M, Mondal MM, Napolitano J, Nikolaev D, Rashad MNH, Owen V, Palatchi C, Pan J, Pandey B, Park S, Paschke KD, Petrusky M, Pitt ML, Premathilake S, Puckett AJR, Quinn B, Radloff R, Rahman S, Rathnayake A, Reed BT, Reimer PE, Richards R, Riordan S, Roblin Y, Seeds S, Shahinyan A, Souder PA, Tang L, Thiel M, Tian Y, Urciuoli GM, Wertz EW, Wojtsekhowski B, Xiong W, Yale B, Ye T, Zec A, Zhang W, Zhang J, Zheng X. New Measurements of the Beam-Normal Single Spin Asymmetry in Elastic Electron Scattering over a Range of Spin-0 Nuclei. Phys Rev Lett 2022; 128:142501. [PMID: 35476486 DOI: 10.1103/physrevlett.128.142501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Revised: 01/31/2022] [Accepted: 02/04/2022] [Indexed: 06/14/2023]
Abstract
We report precision determinations of the beam-normal single spin asymmetries (A_{n}) in the elastic scattering of 0.95 and 2.18 GeV electrons off ^{12}C, ^{40}Ca, ^{48}Ca, and ^{208}Pb at very forward angles where the most detailed theoretical calculations have been performed. The first measurements of A_{n} for ^{40}Ca and ^{48}Ca are found to be similar to that of ^{12}C, consistent with expectations and thus demonstrating the validity of theoretical calculations for nuclei with Z≤20. We also report A_{n} for ^{208}Pb at two new momentum transfers (Q^{2}) extending the previous measurement. Our new data confirm the surprising result previously reported, with all three data points showing significant disagreement with the results from the Z≤20 nuclei. These data confirm our basic understanding of the underlying dynamics that govern A_{n} for nuclei containing ≲50 nucleons, but point to the need for further investigation to understand the unusual A_{n} behavior discovered for scattering off ^{208}Pb.
Collapse
Affiliation(s)
- D Adhikari
- Idaho State University, Pocatello, Idaho 83209, USA
| | - H Albataineh
- Texas A & M University - Kingsville, Kingsville, Texas 78363, USA
| | - D Androic
- University of Zagreb, Faculty of Science, Zagreb HR 10002, Croatia
| | - K Aniol
- California State University, Los Angeles, Los Angeles, California 90032, USA
| | | | - T Averett
- William & Mary, Williamsburg, Virginia 23185, USA
| | | | - S Barcus
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Bellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Catania, 95123 Catania, Italy
| | | | - J F Benesch
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Bhatt
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | | | - D Bhetuwal
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - B Blaikie
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - J Boyd
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - Q Campagna
- William & Mary, Williamsburg, Virginia 23185, USA
| | - A Camsonne
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - G D Cates
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - Y Chen
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - C Clarke
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - J C Cornejo
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - S Covrig Dusa
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M M Dalton
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Datta
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Deshpande
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- Center for Frontiers in Nuclear Science, Stony Brook, New York 11794, USA
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - D Dutta
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - C Feldman
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- Institute for Advanced Computational Science, Stony Brook, New York 11794, USA
| | - E Fuchey
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - C Gal
- Mississippi State University, Mississippi State, Mississippi 39762, USA
- University of Virginia, Charlottesville, Virginia 22904, USA
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- Center for Frontiers in Nuclear Science, Stony Brook, New York 11794, USA
| | - D Gaskell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T Gautam
- Hampton University, Hampton, Virginia 23668, USA
| | - M Gericke
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - C Ghosh
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - I Halilovic
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - J-O Hansen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - F Hauenstein
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - W Henry
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - C J Horowitz
- Indiana University, Bloomington, Indiana 47405, USA
| | - C Jantzi
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - S Jian
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - S Johnston
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - D C Jones
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - B Karki
- Ohio University, Athens, Ohio 45701, USA
| | - S Kakkar
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - S Katugampola
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - C E Keppel
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P M King
- Ohio University, Athens, Ohio 45701, USA
| | - D E King
- Syracuse University, Syracuse, New York 13244, USA
| | - M Knauss
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - K S Kumar
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - T Kutz
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | | | - G Leverick
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - H Liu
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - N Liyange
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - S Malace
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Mammei
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - R Mammei
- University of Winnipeg, Winnipeg, Manitoba R3B2E9, Canada
| | - M McCaughan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D McNulty
- Idaho State University, Pocatello, Idaho 83209, USA
| | - D Meekins
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Metts
- William & Mary, Williamsburg, Virginia 23185, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Mihovilovic
- Jôzef Stefan Institute, Ljubljana 1000, Slovenia
- Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana 1000, Slovenia
| | - M M Mondal
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- Center for Frontiers in Nuclear Science, Stony Brook, New York 11794, USA
| | - J Napolitano
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - D Nikolaev
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - M N H Rashad
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Owen
- William & Mary, Williamsburg, Virginia 23185, USA
| | - C Palatchi
- University of Virginia, Charlottesville, Virginia 22904, USA
- Center for Frontiers in Nuclear Science, Stony Brook, New York 11794, USA
| | - J Pan
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - B Pandey
- Hampton University, Hampton, Virginia 23668, USA
| | - S Park
- Mississippi State University, Mississippi State, Mississippi 39762, USA
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - K D Paschke
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - M Petrusky
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- University of Colorado Boulder, Boulder, Colorado 80309, USA
| | - M L Pitt
- Virginia Tech, Blacksburg, Virginia 24061, USA
| | - S Premathilake
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - A J R Puckett
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - B Quinn
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - R Radloff
- Ohio University, Athens, Ohio 45701, USA
| | - S Rahman
- University of Manitoba, Winnipeg, Manitoba R3T2N2, Canada
| | - A Rathnayake
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - B T Reed
- Indiana University, Bloomington, Indiana 47405, USA
| | - P E Reimer
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - R Richards
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - S Riordan
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - Y Roblin
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Seeds
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Shahinyan
- A. I. Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan 0036, Armenia
| | - P A Souder
- Syracuse University, Syracuse, New York 13244, USA
| | - L Tang
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Hampton University, Hampton, Virginia 23668, USA
| | - M Thiel
- Institut für Kernphysik, Johannes Gutenberg-Universität, Mainz 55099, Germany
| | - Y Tian
- Syracuse University, Syracuse, New York 13244, USA
| | | | - E W Wertz
- William & Mary, Williamsburg, Virginia 23185, USA
| | - B Wojtsekhowski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Xiong
- Syracuse University, Syracuse, New York 13244, USA
| | - B Yale
- William & Mary, Williamsburg, Virginia 23185, USA
| | - T Ye
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - A Zec
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - W Zhang
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
| | - J Zhang
- Stony Brook, State University of New York, Stony Brook, New York 11794, USA
- Center for Frontiers in Nuclear Science, Stony Brook, New York 11794, USA
- Shandong University, Qingdao, Shandong 266237, China
| | - X Zheng
- University of Virginia, Charlottesville, Virginia 22904, USA
| |
Collapse
|
26
|
Aaltonen T, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel JA, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Auerbach B, Aurisano A, Azfar F, Badgett W, Bae T, Barbaro-Galtieri A, Barnes VE, Barnett BA, Barria P, Bartos P, Bauce M, Bedeschi F, Behari S, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Bhatti A, Bland KR, Blumenfeld B, Bocci A, Bodek A, Bortoletto D, Boudreau J, Boveia A, Brigliadori L, Bromberg C, Brucken E, Budagov J, Budd HS, Burkett K, Busetto G, Bussey P, Butti P, Buzatu A, Calamba A, Camarda S, Campanelli M, Carls B, Carlsmith D, Carosi R, Carrillo S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavaliere V, Cerri A, Cerrito L, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Cho K, Chokheli D, Clark A, Clarke C, Convery ME, Conway J, Corbo M, Cordelli M, Cox CA, Cox DJ, Cremonesi M, Cruz D, Cuevas J, Culbertson R, d'Ascenzo N, Datta M, de Barbaro P, Demortier L, Deninno M, D'Errico M, Devoto F, Di Canto A, Di Ruzza B, Dittmann JR, Donati S, D'Onofrio M, Dorigo M, Driutti A, Ebina K, Edgar R, Elagin A, Erbacher R, Errede S, Esham B, Farrington S, Fernández Ramos JP, Field R, Flanagan G, Forrest R, Franklin M, Freeman JC, Frisch H, Funakoshi Y, Galloni C, Garfinkel AF, Garosi P, Gerberich H, Gerchtein E, Giagu S, Giakoumopoulou V, Gibson K, Ginsburg CM, Giokaris N, Giromini P, Glagolev V, Glenzinski D, Gold M, Goldin D, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González López O, Gorelov I, Goshaw AT, Goulianos K, Gramellini E, Grosso-Pilcher C, Guimaraes da Costa J, Hahn SR, Han JY, Happacher F, Hara K, Hare M, Harr RF, Harrington-Taber T, Hatakeyama K, Hays C, Heinrich J, Herndon M, Hocker A, Hong Z, Hopkins W, Hou S, Hughes RE, Husemann U, Hussein M, Huston J, Introzzi G, Iori M, Ivanov A, James E, Jang D, Jayatilaka B, Jeon EJ, Jindariani S, Jones M, Joo KK, Jun SY, Junk TR, Kambeitz M, Kamon T, Karchin PE, Kasmi A, Kato Y, Ketchum W, Keung J, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SH, Kim SB, Kim YJ, Kim YK, Kimura N, Kirby M, Kondo K, Kong DJ, Konigsberg J, Kotwal AV, Kreps M, Kroll J, Kruse M, Kuhr T, Kurata M, Laasanen AT, Lammel S, Lancaster M, Lannon K, Latino G, Lee HS, Lee JS, Leo S, Leone S, Lewis JD, Limosani A, Lipeles E, Lister A, Liu Q, Liu T, Lockwitz S, Loginov A, Lucchesi D, Lucà A, Lueck J, Lujan P, Lukens P, Lungu G, Lys J, Lysak R, Madrak R, Maestro P, Malik S, Manca G, Manousakis-Katsikakis A, Marchese L, Margaroli F, Marino P, Matera K, Mattson ME, Mazzacane A, Mazzanti P, McNulty R, Mehta A, Mehtala P, Menzione A, Mesropian C, Miao T, Michielin E, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Moon CS, Moore R, Morello MJ, Mukherjee A, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nakano I, Napier A, Nett J, Nigmanov T, Nodulman L, Noh SY, Norniella O, Oakes L, Oh SH, Oh YD, Okusawa T, Orava R, Ortolan L, Pagliarone C, Palencia E, Palni P, Papadimitriou V, Parker W, Pauletta G, Paulini M, Paus C, Phillips TJ, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pondrom L, Poprocki S, Potamianos K, Pranko A, Prokoshin F, Ptohos F, Punzi G, Redondo Fernández I, Renton P, Rescigno M, Rimondi F, Ristori L, Robson A, Rodriguez T, Rolli S, Ronzani M, Roser R, Rosner JL, Ruffini F, Ruiz A, Russ J, Rusu V, Sakumoto WK, Sakurai Y, Santi L, Sato K, Saveliev V, Savoy-Navarro A, Schlabach P, Schmidt EE, Schwarz T, Scodellaro L, Scuri F, Seidel S, Seiya Y, Semenov A, Sforza F, Shalhout SZ, Shears T, Shepard PF, Shimojima M, Shochet M, Shreyber-Tecker I, Simonenko A, Sliwa K, Smith JR, Snider FD, Song H, Sorin V, St Denis R, Stancari M, Stentz D, Strologas J, Sudo Y, Sukhanov A, Suslov I, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng PK, Thom J, Thomson E, Thukral V, Toback D, Tokar S, Tollefson K, Tomura T, Torre S, Torretta D, Totaro P, Trovato M, Ukegawa F, Uozumi S, Vázquez F, Velev G, Vellidis K, Vernieri C, Vidal M, Vilar R, Vizán J, Vogel M, Volpi G, Wagner P, Wallny R, Wang SM, Waters D, Wester WC, Whiteson D, Wicklund AB, Wilbur S, Williams HH, Wilson JS, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfmeister H, Wright T, Wu X, Wu Z, Yamamoto K, Yamato D, Yang T, Yang UK, Yang YC, Yao WM, Yeh GP, Yi K, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Zanetti AM, Zeng Y, Zhou C, Zucchelli S. High-precision measurement of the W boson mass with the CDF II detector. Science 2022; 376:170-176. [PMID: 35389814 DOI: 10.1126/science.abk1781] [Citation(s) in RCA: 77] [Impact Index Per Article: 38.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
The mass of the W boson, a mediator of the weak force between elementary particles, is tightly constrained by the symmetries of the standard model of particle physics. The Higgs boson was the last missing component of the model. After observation of the Higgs boson, a measurement of the W boson mass provides a stringent test of the model. We measure the W boson mass, MW, using data corresponding to 8.8 inverse femtobarns of integrated luminosity collected in proton-antiproton collisions at a 1.96 tera-electron volt center-of-mass energy with the CDF II detector at the Fermilab Tevatron collider. A sample of approximately 4 million W boson candidates is used to obtain [Formula: see text], the precision of which exceeds that of all previous measurements combined (stat, statistical uncertainty; syst, systematic uncertainty; MeV, mega-electron volts; c, speed of light in a vacuum). This measurement is in significant tension with the standard model expectation.
Collapse
Affiliation(s)
| | - T Aaltonen
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland.,Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | - S Amerio
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - D Amidei
- University of Michigan, Ann Arbor, MI 48109, USA
| | - A Anastassov
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - A Annovi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Antos
- Comenius University, 842 48 Bratislava, Slovakia.,Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - G Apollinari
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J A Appel
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | | | - A Artikov
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - J Asaadi
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - W Ashmanskas
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - B Auerbach
- Argonne National Laboratory, Argonne, IL 60439, USA
| | - A Aurisano
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - F Azfar
- University of Oxford, Oxford OX1 3RH, UK
| | - W Badgett
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - T Bae
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - A Barbaro-Galtieri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - V E Barnes
- Purdue University, West Lafayette, IN 47907, USA
| | - B A Barnett
- The Johns Hopkins University, Baltimore, MD 21218, USA
| | - P Barria
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Siena, I-53100 Siena, Italy
| | - P Bartos
- Comenius University, 842 48 Bratislava, Slovakia.,Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - M Bauce
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - F Bedeschi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Behari
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - G Bellettini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - J Bellinger
- University of Wisconsin-Madison, Madison, WI 53706, USA
| | | | - A Beretvas
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - A Bhatti
- The Rockefeller University, New York, NY 10065, USA
| | - K R Bland
- Baylor University, Waco, TX 76798, USA
| | - B Blumenfeld
- The Johns Hopkins University, Baltimore, MD 21218, USA
| | - A Bocci
- Duke University, Durham, NC 27708, USA
| | - A Bodek
- University of Rochester, Rochester, NY 14627, USA
| | - D Bortoletto
- Purdue University, West Lafayette, IN 47907, USA
| | - J Boudreau
- University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - A Boveia
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - L Brigliadori
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy.,University of Bologna, I-40127 Bologna, Italy
| | - C Bromberg
- Michigan State University, East Lansing, MI 48824, USA
| | - E Brucken
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland.,Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | - J Budagov
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - H S Budd
- University of Rochester, Rochester, NY 14627, USA
| | - K Burkett
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - G Busetto
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - P Bussey
- Glasgow University, Glasgow G12 8QQ, UK
| | - P Butti
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - A Buzatu
- Glasgow University, Glasgow G12 8QQ, UK
| | - A Calamba
- Carnegie Mellon University, Pittsburgh, PA 15213, USA
| | - S Camarda
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193 Bellaterra (Barcelona), Spain
| | | | - B Carls
- University of Illinois, Urbana, IL 61801, USA
| | - D Carlsmith
- University of Wisconsin-Madison, Madison, WI 53706, USA
| | - R Carosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Carrillo
- University of Florida, Gainesville, FL 32611, USA
| | - B Casal
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Casarsa
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy
| | - A Castro
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy.,University of Bologna, I-40127 Bologna, Italy
| | - P Catastini
- Harvard University, Cambridge, MA 02138, USA
| | - D Cauz
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy.,Gruppo Collegato di Udine, I-33100 Udine, Italy.,University of Udine, I-33100 Udine, Italy
| | - V Cavaliere
- University of Illinois, Urbana, IL 61801, USA
| | - A Cerri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - L Cerrito
- University College London, London WC1E 6BT, UK
| | - Y C Chen
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - M Chertok
- University of California, Davis, Davis, CA 95616, USA
| | - G Chiarelli
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - G Chlachidze
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Cho
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - D Chokheli
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - A Clark
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - C Clarke
- Wayne State University, Detroit, MI 48201, USA
| | - M E Convery
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J Conway
- University of California, Davis, Davis, CA 95616, USA
| | - M Corbo
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Cordelli
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - C A Cox
- University of California, Davis, Davis, CA 95616, USA
| | - D J Cox
- University of California, Davis, Davis, CA 95616, USA
| | - M Cremonesi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - D Cruz
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - J Cuevas
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - R Culbertson
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - N d'Ascenzo
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Datta
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - P de Barbaro
- University of Rochester, Rochester, NY 14627, USA
| | - L Demortier
- The Rockefeller University, New York, NY 10065, USA
| | - M Deninno
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - M D'Errico
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - F Devoto
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland.,Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | - A Di Canto
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - B Di Ruzza
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | | | - S Donati
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - M D'Onofrio
- University of Liverpool, Liverpool L69 7ZE, UK
| | - M Dorigo
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy.,University of Trieste, I-34127 Trieste, Italy
| | - A Driutti
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy.,Gruppo Collegato di Udine, I-33100 Udine, Italy.,University of Udine, I-33100 Udine, Italy
| | - K Ebina
- Waseda University, Tokyo 169, Japan
| | - R Edgar
- University of Michigan, Ann Arbor, MI 48109, USA
| | - A Elagin
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - R Erbacher
- University of California, Davis, Davis, CA 95616, USA
| | - S Errede
- University of Illinois, Urbana, IL 61801, USA
| | - B Esham
- University of Illinois, Urbana, IL 61801, USA
| | | | - J P Fernández Ramos
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - R Field
- University of Florida, Gainesville, FL 32611, USA
| | - G Flanagan
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - R Forrest
- University of California, Davis, Davis, CA 95616, USA
| | - M Franklin
- Harvard University, Cambridge, MA 02138, USA
| | - J C Freeman
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - H Frisch
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | | | - C Galloni
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | | | - P Garosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Siena, I-53100 Siena, Italy
| | - H Gerberich
- University of Illinois, Urbana, IL 61801, USA
| | - E Gerchtein
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - S Giagu
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - V Giakoumopoulou
- National and Kapodistrian University of Athens, 157 71 Athens, Greece
| | - K Gibson
- University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - C M Ginsburg
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - N Giokaris
- National and Kapodistrian University of Athens, 157 71 Athens, Greece
| | - P Giromini
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - V Glagolev
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - D Glenzinski
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Gold
- University of New Mexico, Albuquerque, NM 87131, USA
| | - D Goldin
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - A Golossanov
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - G Gomez
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | | | - M Goncharov
- Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - O González López
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - I Gorelov
- University of New Mexico, Albuquerque, NM 87131, USA
| | | | - K Goulianos
- The Rockefeller University, New York, NY 10065, USA
| | - E Gramellini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - C Grosso-Pilcher
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | | | - S R Hahn
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J Y Han
- University of Rochester, Rochester, NY 14627, USA
| | - F Happacher
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - K Hara
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Hare
- Tufts University, Medford, MA 02155, USA
| | - R F Harr
- Wayne State University, Detroit, MI 48201, USA
| | | | | | - C Hays
- University of Oxford, Oxford OX1 3RH, UK
| | - J Heinrich
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - M Herndon
- University of Wisconsin-Madison, Madison, WI 53706, USA
| | - A Hocker
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - Z Hong
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - W Hopkins
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - S Hou
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - R E Hughes
- The Ohio State University, Columbus, OH 43210, USA
| | - U Husemann
- Yale University, New Haven, CT 06520, USA
| | - M Hussein
- Michigan State University, East Lansing, MI 48824, USA
| | - J Huston
- Michigan State University, East Lansing, MI 48824, USA
| | - G Introzzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,Istituto Nazionale di Fisica Nucleare Pavia, I-27100 Pavia, Italy.,University of Pavia, I-27100 Pavia, Italy
| | - M Iori
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy.,Sapienza Università di Roma, I-00185 Roma, Italy
| | - A Ivanov
- University of California, Davis, Davis, CA 95616, USA
| | - E James
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - D Jang
- Carnegie Mellon University, Pittsburgh, PA 15213, USA
| | - B Jayatilaka
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - E J Jeon
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - S Jindariani
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Jones
- Purdue University, West Lafayette, IN 47907, USA
| | - K K Joo
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - S Y Jun
- Carnegie Mellon University, Pittsburgh, PA 15213, USA
| | - T R Junk
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Kambeitz
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - T Kamon
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA.,Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - P E Karchin
- Wayne State University, Detroit, MI 48201, USA
| | - A Kasmi
- Baylor University, Waco, TX 76798, USA
| | - Y Kato
- Osaka City University, Osaka 558-8585, Japan
| | - W Ketchum
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - J Keung
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - B Kilminster
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - D H Kim
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - H S Kim
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J E Kim
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - M J Kim
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - S H Kim
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S B Kim
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - Y J Kim
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - Y K Kim
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - N Kimura
- Waseda University, Tokyo 169, Japan
| | - M Kirby
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Kondo
- Waseda University, Tokyo 169, Japan
| | - D J Kong
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - J Konigsberg
- University of Florida, Gainesville, FL 32611, USA
| | | | - M Kreps
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - J Kroll
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - M Kruse
- Duke University, Durham, NC 27708, USA
| | - T Kuhr
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - M Kurata
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A T Laasanen
- Purdue University, West Lafayette, IN 47907, USA
| | - S Lammel
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Lancaster
- University College London, London WC1E 6BT, UK
| | - K Lannon
- The Ohio State University, Columbus, OH 43210, USA
| | - G Latino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Siena, I-53100 Siena, Italy
| | - H S Lee
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - J S Lee
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - S Leo
- University of Illinois, Urbana, IL 61801, USA
| | - S Leone
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - J D Lewis
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | | | - E Lipeles
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - A Lister
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Q Liu
- Purdue University, West Lafayette, IN 47907, USA
| | - T Liu
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - S Lockwitz
- Yale University, New Haven, CT 06520, USA
| | - A Loginov
- Yale University, New Haven, CT 06520, USA
| | - D Lucchesi
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - A Lucà
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA.,Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Lueck
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Lujan
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - P Lukens
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - G Lungu
- The Rockefeller University, New York, NY 10065, USA
| | - J Lys
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - R Lysak
- Comenius University, 842 48 Bratislava, Slovakia.,Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - R Madrak
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - P Maestro
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Siena, I-53100 Siena, Italy
| | - S Malik
- The Rockefeller University, New York, NY 10065, USA
| | - G Manca
- University of Liverpool, Liverpool L69 7ZE, UK
| | | | - L Marchese
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - F Margaroli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - P Marino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,Scuola Normale Superiore, I-56126 Pisa, Italy
| | - K Matera
- University of Illinois, Urbana, IL 61801, USA
| | - M E Mattson
- Wayne State University, Detroit, MI 48201, USA
| | - A Mazzacane
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - P Mazzanti
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - R McNulty
- University of Liverpool, Liverpool L69 7ZE, UK
| | - A Mehta
- University of Liverpool, Liverpool L69 7ZE, UK
| | - P Mehtala
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland.,Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | - A Menzione
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - C Mesropian
- The Rockefeller University, New York, NY 10065, USA
| | - T Miao
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - E Michielin
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - D Mietlicki
- University of Michigan, Ann Arbor, MI 48109, USA
| | - A Mitra
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - H Miyake
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Moed
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - N Moggi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - C S Moon
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - R Moore
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M J Morello
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,Scuola Normale Superiore, I-56126 Pisa, Italy
| | - A Mukherjee
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - Th Muller
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Murat
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Mussini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy.,University of Bologna, I-40127 Bologna, Italy
| | - J Nachtman
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - Y Nagai
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | | | - I Nakano
- Okayama University, Okayama 700-8530, Japan
| | - A Napier
- Tufts University, Medford, MA 02155, USA
| | - J Nett
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - T Nigmanov
- University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - L Nodulman
- Argonne National Laboratory, Argonne, IL 60439, USA
| | - S Y Noh
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - O Norniella
- University of Illinois, Urbana, IL 61801, USA
| | - L Oakes
- University of Oxford, Oxford OX1 3RH, UK
| | - S H Oh
- Duke University, Durham, NC 27708, USA
| | - Y D Oh
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - T Okusawa
- Osaka City University, Osaka 558-8585, Japan
| | - R Orava
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland.,Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | - L Ortolan
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193 Bellaterra (Barcelona), Spain
| | - C Pagliarone
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy
| | - E Palencia
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - P Palni
- University of New Mexico, Albuquerque, NM 87131, USA
| | - V Papadimitriou
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - W Parker
- University of Wisconsin-Madison, Madison, WI 53706, USA
| | - G Pauletta
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy.,Gruppo Collegato di Udine, I-33100 Udine, Italy.,University of Udine, I-33100 Udine, Italy
| | - M Paulini
- Carnegie Mellon University, Pittsburgh, PA 15213, USA
| | - C Paus
- Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | | | - G Piacentino
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - E Pianori
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - J Pilot
- University of California, Davis, Davis, CA 95616, USA
| | - K Pitts
- University of Illinois, Urbana, IL 61801, USA
| | - C Plager
- University of California, Los Angeles, Los Angeles, CA 90024, USA
| | - L Pondrom
- University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S Poprocki
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Potamianos
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - A Pranko
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - F Prokoshin
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - F Ptohos
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - G Punzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - I Redondo Fernández
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - P Renton
- University of Oxford, Oxford OX1 3RH, UK
| | - M Rescigno
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - F Rimondi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - L Ristori
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA.,Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - A Robson
- Glasgow University, Glasgow G12 8QQ, UK
| | - T Rodriguez
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - S Rolli
- Tufts University, Medford, MA 02155, USA
| | - M Ronzani
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - R Roser
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J L Rosner
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - F Ruffini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Siena, I-53100 Siena, Italy
| | - A Ruiz
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Russ
- Carnegie Mellon University, Pittsburgh, PA 15213, USA
| | - V Rusu
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - W K Sakumoto
- University of Rochester, Rochester, NY 14627, USA
| | | | - L Santi
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy.,Gruppo Collegato di Udine, I-33100 Udine, Italy.,University of Udine, I-33100 Udine, Italy
| | - K Sato
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - V Saveliev
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - A Savoy-Navarro
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - P Schlabach
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - E E Schmidt
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - T Schwarz
- University of Michigan, Ann Arbor, MI 48109, USA
| | - L Scodellaro
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - F Scuri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Seidel
- University of New Mexico, Albuquerque, NM 87131, USA
| | - Y Seiya
- Osaka City University, Osaka 558-8585, Japan
| | - A Semenov
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - F Sforza
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - S Z Shalhout
- University of California, Davis, Davis, CA 95616, USA
| | - T Shears
- University of Liverpool, Liverpool L69 7ZE, UK
| | - P F Shepard
- University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - M Shimojima
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Shochet
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - I Shreyber-Tecker
- Institution for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - A Simonenko
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - K Sliwa
- Tufts University, Medford, MA 02155, USA
| | - J R Smith
- University of California, Davis, Davis, CA 95616, USA
| | - F D Snider
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - H Song
- University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - V Sorin
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193 Bellaterra (Barcelona), Spain
| | | | - M Stancari
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - D Stentz
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J Strologas
- University of New Mexico, Albuquerque, NM 87131, USA
| | - Y Sudo
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A Sukhanov
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - I Suslov
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - K Takemasa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - Y Takeuchi
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - J Tang
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - M Tecchio
- University of Michigan, Ann Arbor, MI 48109, USA
| | - P K Teng
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - J Thom
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - E Thomson
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - V Thukral
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - D Toback
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - S Tokar
- Comenius University, 842 48 Bratislava, Slovakia.,Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - K Tollefson
- Michigan State University, East Lansing, MI 48824, USA
| | - T Tomura
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Torre
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - D Torretta
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - P Totaro
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
| | - M Trovato
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,Scuola Normale Superiore, I-56126 Pisa, Italy
| | - F Ukegawa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Uozumi
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - F Vázquez
- University of Florida, Gainesville, FL 32611, USA
| | - G Velev
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Vellidis
- National and Kapodistrian University of Athens, 157 71 Athens, Greece
| | - C Vernieri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,Scuola Normale Superiore, I-56126 Pisa, Italy
| | - M Vidal
- Purdue University, West Lafayette, IN 47907, USA
| | - R Vilar
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Vizán
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Vogel
- University of New Mexico, Albuquerque, NM 87131, USA
| | - G Volpi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - P Wagner
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - R Wallny
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - S M Wang
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - D Waters
- University College London, London WC1E 6BT, UK
| | - W C Wester
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - D Whiteson
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - A B Wicklund
- Argonne National Laboratory, Argonne, IL 60439, USA
| | - S Wilbur
- University of California, Davis, Davis, CA 95616, USA
| | - H H Williams
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - J S Wilson
- University of Michigan, Ann Arbor, MI 48109, USA
| | - P Wilson
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - B L Winer
- The Ohio State University, Columbus, OH 43210, USA
| | - P Wittich
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - S Wolbers
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | | | - T Wright
- University of Michigan, Ann Arbor, MI 48109, USA
| | - X Wu
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Z Wu
- Baylor University, Waco, TX 76798, USA
| | - K Yamamoto
- Osaka City University, Osaka 558-8585, Japan
| | - D Yamato
- Osaka City University, Osaka 558-8585, Japan
| | - T Yang
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - U K Yang
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - Y C Yang
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - W-M Yao
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - G P Yeh
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Yi
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J Yoh
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Yorita
- Waseda University, Tokyo 169, Japan
| | - T Yoshida
- Osaka City University, Osaka 558-8585, Japan
| | - G B Yu
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - I Yu
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - A M Zanetti
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy
| | - Y Zeng
- Duke University, Durham, NC 27708, USA
| | - C Zhou
- Duke University, Durham, NC 27708, USA
| | - S Zucchelli
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy.,University of Bologna, I-40127 Bologna, Italy
| |
Collapse
|
27
|
Correll CU, Chepke C, Gionfriddo P, Parks J, Foxworth P, Basu A, Brister TS, Brown D, Clarke C, Hassoun Y. The post COVID-19 healthcare landscape and the use of long-acting injectable antipsychotics for individuals with schizophrenia and bipolar I disorder: the importance of an integrated collaborative-care approach. BMC Psychiatry 2022; 22:32. [PMID: 35012512 PMCID: PMC8745550 DOI: 10.1186/s12888-022-03685-w] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Accepted: 12/17/2021] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND Long-acting injectable antipsychotics (LAIs) are an essential maintenance treatment option for individuals with schizophrenia or bipolar I disorder (BP-I). This report summarizes a roundtable discussion on the impact of COVID-19 on the mental healthcare landscape and use of LAIs for individuals with schizophrenia or BP-I. METHODS Ten experts and stakeholders from diverse fields of healthcare participated in a roundtable discussion on the impact of the COVID-19 pandemic, treatment challenges, and gaps in healthcare for individuals with schizophrenia or BP-I, informed by a literature search. RESULTS Individuals with schizophrenia or BP-I are at increased risk of COVID-19 infection and increased risk of mortality after COVID-19 diagnosis. LAI prescriptions decreased early on in the pandemic, driven by a decrease in face-to-face consultations. Mental healthcare services are adapting with increased use of telehealth and home-based treatment. Clinical workflows to provide consistent, in-person LAI services include screening for COVID-19 exposure and infection, minimizing contact, and ensuring mask-wearing by individuals and staff. The importance of continued in-person visits for LAIs needs to be discussed so that staff can share that information with patients, their caregivers, and families. A fully integrated, collaborative-care model is the most important aspect of care for individuals with schizophrenia or BP-I during and after the COVID-19 pandemic. CONCLUSIONS The COVID-19 pandemic has highlighted the importance of a fully integrated collaborative-care model to ensure regular, routine healthcare contact and access to prescribed treatments and services for individuals with schizophrenia and BP-I.
Collapse
Affiliation(s)
- Christoph U Correll
- The Zucker Hillside Hospital, Department of Psychiatry Research, Northwell Health, 75-59 263rd Street, Glen Oaks, NY, 11004, USA.
- Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA.
- Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.
| | - Craig Chepke
- Excel Psychiatric Associates, Huntersville, NC, USA
| | | | - Joe Parks
- National Council for Behavioral Health, Washington, DC, USA
| | | | - Anirban Basu
- The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, Departments of Pharmacy, Health Services, and Economics, University of Washington, Seattle, WA, USA
| | | | - Dawn Brown
- National Alliance on Mental Illness, Arlington, VA, USA
| | - Christopher Clarke
- Enterprise Digital Health, University of Southern California, Los Angeles, CA, USA
| | - Youssef Hassoun
- The Zucker Hillside Hospital, Department of Psychiatry Research, Northwell Health, 75-59 263rd Street, Glen Oaks, NY, 11004, USA
| |
Collapse
|
28
|
Alyami A, Hoad CL, Tench C, Bannur U, Clarke C, Latief K, Argyriou K, Lobo A, Lung P, Baldwin-Cleland R, Sahnan K, Hart A, Limdi JK, Mclaughlin J, Atkinson D, Parker GJM, O’Connor JPB, Little RA, Gowland PA, Moran GW. Quantitative Magnetic Resonance Imaging in Perianal Crohn's Disease at 1.5 and 3.0 T: A Feasibility Study. Diagnostics (Basel) 2021; 11:2135. [PMID: 34829482 PMCID: PMC8624877 DOI: 10.3390/diagnostics11112135] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Revised: 11/08/2021] [Accepted: 11/12/2021] [Indexed: 01/06/2023] Open
Abstract
Perianal Crohn's Disease (pCD) is a common manifestation of Crohn's Disease. Absence of reliable disease measures makes disease monitoring unreliable. Qualitative MRI has been increasingly used for diagnosing and monitoring pCD and has shown potential for assessing response to treatment. Quantitative MRI sequences, such as diffusion-weighted imaging (DWI), dynamic contrast enhancement (DCE) and magnetisation transfer (MT), along with T2 relaxometry, offer opportunities to improve diagnostic capability. Quantitative MRI sequences (DWI, DCE, MT and T2) were used in a cohort of 25 pCD patients before and 12 weeks after biological therapy at two different field strengths (1.5 and 3 T). Disease activity was measured with the Perianal Crohn's Disease Activity index (PDAI) and serum C-reactive protein (CRP). Diseased tissue areas on MRI were defined by a radiologist. A baseline model to predict outcome at 12 weeks was developed. No differences were seen in the quantitative MR measured in the diseased tissue regions from baseline to 12 weeks; however, PDAI and CRP decreased. Baseline PDAI, CRP, T2 relaxometry and surgical history were found to have a moderate ability to predict response after 12 weeks of biological treatment. Validation in larger cohorts with MRI and clinical measures are needed in order to further develop the model.
Collapse
Affiliation(s)
- Ali Alyami
- Department of Diagnostic Radiography Technology, College of Applied Medical Sciences, Jazan University, Jazan 45142, Saudi Arabia;
- Translational Medical Sciences Academic Unit, School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2UH, UK;
- National Institute of Health Research Nottingham Biomedical Research Centre at the Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, UK; (C.L.H.); (C.T.); (P.A.G.)
| | - Caroline L. Hoad
- National Institute of Health Research Nottingham Biomedical Research Centre at the Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, UK; (C.L.H.); (C.T.); (P.A.G.)
- Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham NG7 2QX, UK
| | - Christopher Tench
- National Institute of Health Research Nottingham Biomedical Research Centre at the Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, UK; (C.L.H.); (C.T.); (P.A.G.)
- Division of Clinical Neurosciences, Clinical Neurology, University of Nottingham, Queen’s Medical Centre, Nottingham NG7 2UH, UK
| | - Uday Bannur
- Department of Radiology, Queens Medical Centre Campus, Nottingham University Hospitals, Nottingham NG7 2UH, UK; (U.B.); (C.C.); (K.L.)
| | - Christopher Clarke
- Department of Radiology, Queens Medical Centre Campus, Nottingham University Hospitals, Nottingham NG7 2UH, UK; (U.B.); (C.C.); (K.L.)
| | - Khalid Latief
- Department of Radiology, Queens Medical Centre Campus, Nottingham University Hospitals, Nottingham NG7 2UH, UK; (U.B.); (C.C.); (K.L.)
| | - Konstantinos Argyriou
- Translational Medical Sciences Academic Unit, School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2UH, UK;
| | - Alan Lobo
- Department of Gastroenterology, Sheffield Teaching Hospitals NHS Trust, Sheffield S10 2JF, UK;
| | - Philip Lung
- Department of Radiology, St Mark’s Hospital and Academic Institute, London North West Healthcare NHS Trust, London HA1 3UJ, UK; (P.L.); (R.B.-C.)
| | - Rachel Baldwin-Cleland
- Department of Radiology, St Mark’s Hospital and Academic Institute, London North West Healthcare NHS Trust, London HA1 3UJ, UK; (P.L.); (R.B.-C.)
| | - Kapil Sahnan
- Fistula Research Unit, St Mark’s Hospital and Academic Institute, London North West Healthcare NHS Trust, London HA1 3UJ, UK; (K.S.); (A.H.)
| | - Ailsa Hart
- Fistula Research Unit, St Mark’s Hospital and Academic Institute, London North West Healthcare NHS Trust, London HA1 3UJ, UK; (K.S.); (A.H.)
| | - Jimmy K. Limdi
- Department of Gastroenterology, The Pennine Acute Hospitals NHS Trust, Greater Manchester, Crumpsall M8 5RB, UK;
| | - John Mclaughlin
- Department of Gastroenterology, Salford Royal NHS Foundation Trust, Manchester Academic Health Sciences Centre, Salford M6 8HD, UK;
| | - David Atkinson
- Centre for Medical Imaging, University College London, London W1W 7TS, UK;
| | - Geoffrey J. M. Parker
- Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London WC1V 6LJ, UK;
- Bioxydyn Limited, Manchester M15 6SZ, UK
| | - James P. B. O’Connor
- Quantitative Biomedical Imaging Laboratory, Division of Cancer Science, University of Manchester, Manchester M13 9PL, UK (R.A.L.)
| | - Ross A. Little
- Quantitative Biomedical Imaging Laboratory, Division of Cancer Science, University of Manchester, Manchester M13 9PL, UK (R.A.L.)
| | - Penny A. Gowland
- National Institute of Health Research Nottingham Biomedical Research Centre at the Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, UK; (C.L.H.); (C.T.); (P.A.G.)
- Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham NG7 2QX, UK
| | - Gordon W. Moran
- Translational Medical Sciences Academic Unit, School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2UH, UK;
- National Institute of Health Research Nottingham Biomedical Research Centre at the Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, UK; (C.L.H.); (C.T.); (P.A.G.)
| |
Collapse
|
29
|
Kuhne M, Chu H, Clarke C, Carr B, Baca M, Hung M, Nagel M, Ambrogelly A, Rajakumaraswamy N. 847 Pharmacokinetics and pharmacodynamics of GS-3583 in cynomolgus monkeys. J Immunother Cancer 2021. [DOI: 10.1136/jitc-2021-sitc2021.847] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
BackgroundThe ligand for the receptor tyrosine kinase FMS-like tyrosine kinase 3 (FLT3) plays an importantrole in hematopoiesis. FLT3 signaling is required for the differentiation andexpansion of dendritic cells. In the context of cancer immunity, the conventional dendritic cellsubtype 1 (cDC1) are required for the generation of tumor-specific T cell responses in mousepreclinical models. In human tumors cDC1 are often underrepresented in thetumor microenvironment, supporting the hypothesis that therapeutically increasing their number via FLT3 pathway stimulation has the potential to promote T cell-mediated anti-tumor activity.MethodsGS-3583 is a fusion protein composed of the extracellular domain of human FLT3 ligand(FLT3L) combined with a modified fragment crystallizable (Fc) region of human IgG4. GS-3583was designed to induce cDC1 expansion and subsequently promote tumor-reactive T cell priming, activation and recruitment into the tumor microenvironment. The pharmacokinetics (PK) and pharmacodynamics (PD) of GS-3583 has been characterized in a 4-week repeat dose GLP study in cynomolgus monkeys at doses ranging from 0.3 to 10mg/kg GS-3583 was given as an intravenous injection.ResultsImmunophenotyping analysis of peripheral blood cells from GS-3583 treated monkeys demonstrated a non-dose-dependent expansion of cDC1 and cDC2 populations. The peak expansion for cDC1 and cDC2 occurred at Day 8 to Day 15. At peak, there was a 160-fold relative increase in cDC1 and 150-fold increase in cDC2 at the highest dose tested. There were dose-dependent increases in the exposure (AUC and Cmax) of GS-3583. GS-3583 was well-tolerated with no mortality or adverse clinical signs.ConclusionsThe administration of GS-3583 leads to increases in cDC1 and cDC2 populations. It was well tolerated at the maximal dose tested with no adverse clinical signs. Further clinical development of GS-3583 is warranted.
Collapse
|
30
|
Kuhne M, Chu H, Ng S, Clarke C, Carr B, Baca M, Hung M, Nagel M, Ambrogelly A, Wilson N. 846 Pre-clinical validation of a FLT3L-fusion protein for dendritic cell expansion and anti-tumor efficacy. J Immunother Cancer 2021. [DOI: 10.1136/jitc-2021-sitc2021.846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
BackgroundThe ligand for the receptor tyrosine kinase FMS-like tyrosine kinase 3 (FLT3) plays an importantrole in hematopoiesis. FLT3 signaling is required for the differentiation andexpansion of dendritic cells. In the context of cancer immunity, the conventional dendritic cellsubtype 1 (cDC1) are required for the generation of tumor-specific T cell responses in mousepreclinical models. In human tumors cDC1 are often underrepresented in thetumor microenvironment, supporting the hypothesis that therapeutically increasing their number via FLT3 pathway stimulation has the potential to promote T cell-mediated anti-tumor efficacy.MethodsGS-3583 is a fusion protein composed of the extracellular domain (ECD) of human FLT3 ligand(FLT3L) combined with a modified fragment crystallizable (Fc) region of human IgG4. GS-3583was designed to induce cDC1 expansion and subsequently promote tumor-reactive T cell priming, activation and recruitment into the tumor microenvironment. To evaluate the therapeutic efficacy of FLT3 stimulation in vivo, a mouse surrogate mGS-3583was designed using the ECD of mouse FLT3L fused to an engineered mouse IgG2a Fc withattenuated binding to mouse FcgRs.Results mGS-3583 bound to recombinant mouse FLT3 with an estimated affinity of 15 nM, and to mouse FLT3-expressing cells with an EC50 of 0.15 nM. In vivo, mGS-3583 showed single agent dose-dependent tumor growth inhibition (TGI) in tumors that correlated with peripheral and intratumoral cDC1 expansion. In tumors with no initial immune infiltration, mGS-3583 led to an influx of T cells into the tumors. In addition to single agent efficacy, mGS-3583 combined effectively with programmed cell death protein (ligand)-1 (PD(L)-1) pathway blockade.ConclusionsIn vivo expansion of dendritic cells can convert uninflamed (cold) tumors to immunologically active (hot) tumors and initiate productive anti-tumor immune responses. These findings support the development GS-3583 as a promising candidate for cancer immunotherapy.
Collapse
|
31
|
Van Buynder PG, Newbound A, MacIntyre CR, Kennedy AT, Clarke C, Anderson J. Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program. Hum Vaccin Immunother 2021; 17:4611-4616. [PMID: 34542384 PMCID: PMC8828056 DOI: 10.1080/21645515.2021.1967042] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Affiliation(s)
| | | | - C Raina MacIntyre
- Biosecurity Research Program, The Kirby Institute, University of New South Wales, Sydney, Australia
| | | | | | | |
Collapse
|
32
|
McDonald L, Clarke C, O’Neill V, Houghton J, Dolan O, McCourt C. Incidence of cutaneous melanoma in patients with histologically confirmed dysplastic naevus: A follow‐up study in a large UK Healthcare Trust. Skin Health and Disease 2021; 1:e44. [PMID: 35663136 PMCID: PMC9060082 DOI: 10.1002/ski2.44] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- L. McDonald
- Department of Dermatology Royal Victoria Hospital Belfast Health and Social Care Trust Belfast UK
| | - C. Clarke
- Department of Histopathology Royal Victoria Hospital Belfast Health and Social Care Trust Belfast UK
| | - V. O’Neill
- School of Medicine, Dentistry and Biomedical Sciences Queen's University Belfast Belfast UK
| | - J. Houghton
- Department of Histopathology Royal Victoria Hospital Belfast Health and Social Care Trust Belfast UK
- School of Medicine, Dentistry and Biomedical Sciences Queen's University Belfast Belfast UK
| | - O. Dolan
- Department of Dermatology Royal Victoria Hospital Belfast Health and Social Care Trust Belfast UK
| | - C. McCourt
- Department of Dermatology Royal Victoria Hospital Belfast Health and Social Care Trust Belfast UK
| |
Collapse
|
33
|
Lee JY, Stevens RP, Kash M, Alexeyev MF, Balczon R, Zhou C, Renema P, Koloteva A, Kozhukhar N, Pastukh V, Gwin MS, Voth S, deWeever A, Wagener BM, Pittet JF, Eslaamizaad Y, Siddiqui W, Nawaz T, Clarke C, Fouty BW, Audia JP, Alvarez DF, Stevens T. Carbonic Anhydrase IX and Hypoxia Promote Rat Pulmonary Endothelial Cell Survival During Infection. Am J Respir Cell Mol Biol 2021; 65:630-645. [PMID: 34251286 DOI: 10.1165/rcmb.2020-0537oc] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Low tidal volume ventilation protects the lung in mechanically ventilated patients. The impact of the accompanying permissive hypoxemia and hypercapnia on endothelial cell recovery from injury is poorly understood. Carbonic anhydrase IX (CA IX) is expressed in pulmonary microvascular endothelial cells (PMVECs), where it contributes to CO2 and pH homeostasis, bioenergetics and angiogenesis. We hypothesized that CA IX is important for PMVEC survival, and CA IX expression and release from PMVECs are increased during infection. While plasma CA IX was unchanged in human and rat pneumonia, there was a trend towards increasing CA IX in bronchoalveolar fluid of mechanically ventilated critically ill pneumonia patients and a significant increase in CA IX in lung tissue lysate of rat pneumonia. To investigate functional implications of the lung CA IX increase, we generated PMVEC cell lines harboring domain-specific CA IX mutations. Using these cells, we found that infection promotes intracellular expression, release and metalloproteinase-mediated extracellular cleavage of CA IX in PMVECs. Intracellular domain deletion uniquely impaired CA IX membrane localization. Loss of the CA IX intracellular domain promoted cell death following infection, suggesting the important role of intracellular domain in PMVEC survival. We also found that hypoxia improves survival, whereas hypercapnia reverses the protective effect of hypoxia, during infection. Thus, we report that: (1) CA IX increases in rat pneumonia lung; and, (2) the CA IX intracellular domain and hypoxia promote PMVEC survival during infection.
Collapse
Affiliation(s)
- Ji Young Lee
- University of South Alabama, 5557, Mobile, Alabama, United States;
| | - Reece P Stevens
- University of South Alabama, 5557, Mobile, Alabama, United States
| | - Mary Kash
- University of South Alabama, 5557, Mobile, Alabama, United States
| | | | - Ronald Balczon
- University of South Alabama, 5557, Biochemistry and Molecular Biology, Mobile, Alabama, United States
| | - Chun Zhou
- University of South Alabama, 5557, Mobile, Alabama, United States
| | - Phoibe Renema
- University of South Alabama, 5557, Mobile, Alabama, United States
| | - Anna Koloteva
- University of South Alabama, 5557, Mobile, Alabama, United States
| | | | | | - Meredith S Gwin
- University of South Alabama, 5557, Physiology and Cell Biology, Mobile, Alabama, United States
| | - Sarah Voth
- University of South Alabama, 5557, Physiology and Cell Biology, Mobile, Alabama, United States
| | - Althea deWeever
- University of South Alabama College of Medicine, 12214, Physiology and Cell Biology, Mobile, Alabama, United States
| | - Brant M Wagener
- The University of Alabama at Birmingham, 9968, Department of Anesthesiology and Perioperative Medicine, Birmingham, Alabama, United States
| | - Jean-François Pittet
- The University of Alabama at Birmingham, 9968, Department of Anesthesiology and Perioperative Medicine, Birmingham, Alabama, United States
| | | | - Waqar Siddiqui
- University of South Alabama, 5557, Mobile, Alabama, United States
| | - Talha Nawaz
- University of South Alabama, 5557, Mobile, Alabama, United States
| | | | - Brian W Fouty
- University of South Alabama, 5557, Mobile, Alabama, United States
| | - Jonathon P Audia
- University of South Alabama, 5557, Mobile, Alabama, United States
| | - Diego F Alvarez
- Sam Houston State University, 4038, Huntsville, Texas, United States
| | - Troy Stevens
- University of South Alabama, 5557, Physiology and Cell Biology, Mobile, Alabama, United States
| |
Collapse
|
34
|
Rajakumaraswamy N, Dauki A, Kuhne MR, Trowe T, He J, Clarke C, Carr B, Worth A, Vashishtha A, Schwabe C, Othman AA. GS-3583, a novel FLT3 agonist Fc fusion protein, to expand conventional dendritic cells in healthy volunteers. J Clin Oncol 2021. [DOI: 10.1200/jco.2021.39.15_suppl.2559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
2559 Background: Conventional dendritic cells subtype 1 (cDC1) play a vital role in the priming and expansion of tumor specific CD8+ T cells and their recruitment to tumor microenvironment (TME). However, cDC1s are often underrepresented in the TME. Systemic administration of Fms-like tyrosine kinase 3 ligand (FLT3L), a hematopoietic growth factor that binds to FLT3 on myeloid and lymphoid progenitor cells, leads to expansion of cDC1s in the periphery which can then be recruited into the TME. We hypothesize that FLT3 pathway stimulation using GS-3583, a FLT3 agonist Fc fusion protein, has the potential to promote T cell mediated anti-tumor activity. Methods: This was a first-in-human placebo-controlled study of GS-3583 in healthy volunteers to evaluate the safety, PK, and PD of escalating single doses (ranging from 75μg to 2000μg) of GS-3583. The study was blinded to the subjects and the investigator. Each dose cohort enrolled 8-12 healthy subjects who received GS-3583 or placebo as single IV infusion at 3:1 ratio. Subjects were observed in the phase 1 unit for 15 days and then for 12 weeks as outpatients. As part of the PD evaluation, we investigated the changes in the number of cDC1s and cDC subtype 2 (cDC2) cells. Results: As of 8th Feb 2021, selected safety, PK and PD data from the first 3 cohorts were available. GS-3583 was well tolerated and all subjects had been discharged. To date, there have been no serious or grade 3 or higher adverse events. Preliminary PK analysis suggested dose-dependent increase in GS-3583 exposure (AUC and Cmax). Preliminary PD analysis shows that administration of GS-3583 resulted in dose-dependent increases in cDC1/cDC2 cells that peaked at day 5 or day 8 and returned to baseline within three weeks of drug administration. Conclusions: GS-3583 was safe and well tolerated and induced dose dependent expansion of dendritic cells in the periphery. In patients with cancer, this increase in dendritic cells can be utilized to enhance anti-tumor responses to immuno-oncology therapies.[Table: see text]
Collapse
Affiliation(s)
| | | | | | | | - Jing He
- Gilead Sciences, Inc., Foster City, CA
| | | | | | | | | | | | | |
Collapse
|
35
|
Abstract
OBJECTIVES The objective of this study was to understand the variables or study habits that inform study in undergraduate and postgraduate students attending Trinity College Dublin. METHODS A descriptive, cross-sectional anonymous online survey was used to gather data to explore student study habits. Survey 1 was completed by participants in April 2019 and survey 2 was completed by participants in April 2020, during the COVID-19 restrictions. RESULTS A total of 1557 participants completed survey 1 in 2019, and 1793 participants completed survey 2 in 2020. In both surveys a majority reported using caffeine, library study, sleep pattern adjustment and excercise to aid academic performance. Survey 2 participants reported COVID-19 resulted in increased difficulty studying (91%). In particular loss of structure and routine was negatively impacted by the pandemic (92%), and increased feelings of stress were reported (75%). CONCLUSIONS Our study suggests a potential role of the college environment as a target for the implementation of interventions to promote student learning, healthy study habits and well-being. The global pandemic has resulted in additional challenging demands for universities to serve an essential role in supporting college students study habits.
Collapse
Affiliation(s)
- C Clarke
- Dublin North Mental Health Services, Millmount Avenue, Drumcondra, Dublin 9, Ireland
| | - M Mullin
- College Health Service, Trinity College Dublin, The University of Dublin, Dublin 2, Ireland
| | - D McGrath
- College Health Service, Trinity College Dublin, The University of Dublin, Dublin 2, Ireland
| | - N Farrelly
- College Health Service, Trinity College Dublin, The University of Dublin, Dublin 2, Ireland
| |
Collapse
|
36
|
Adhikari D, Albataineh H, Androic D, Aniol K, Armstrong DS, Averett T, Ayerbe Gayoso C, Barcus S, Bellini V, Beminiwattha RS, Benesch JF, Bhatt H, Bhatta Pathak D, Bhetuwal D, Blaikie B, Campagna Q, Camsonne A, Cates GD, Chen Y, Clarke C, Cornejo JC, Covrig Dusa S, Datta P, Deshpande A, Dutta D, Feldman C, Fuchey E, Gal C, Gaskell D, Gautam T, Gericke M, Ghosh C, Halilovic I, Hansen JO, Hauenstein F, Henry W, Horowitz CJ, Jantzi C, Jian S, Johnston S, Jones DC, Karki B, Katugampola S, Keppel C, King PM, King DE, Knauss M, Kumar KS, Kutz T, Lashley-Colthirst N, Leverick G, Liu H, Liyange N, Malace S, Mammei R, Mammei J, McCaughan M, McNulty D, Meekins D, Metts C, Michaels R, Mondal MM, Napolitano J, Narayan A, Nikolaev D, Rashad MNH, Owen V, Palatchi C, Pan J, Pandey B, Park S, Paschke KD, Petrusky M, Pitt ML, Premathilake S, Puckett AJR, Quinn B, Radloff R, Rahman S, Rathnayake A, Reed BT, Reimer PE, Richards R, Riordan S, Roblin Y, Seeds S, Shahinyan A, Souder P, Tang L, Thiel M, Tian Y, Urciuoli GM, Wertz EW, Wojtsekhowski B, Yale B, Ye T, Yoon A, Zec A, Zhang W, Zhang J, Zheng X. Accurate Determination of the Neutron Skin Thickness of ^{208}Pb through Parity-Violation in Electron Scattering. Phys Rev Lett 2021; 126:172502. [PMID: 33988387 DOI: 10.1103/physrevlett.126.172502] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/22/2021] [Accepted: 03/22/2021] [Indexed: 06/12/2023]
Abstract
We report a precision measurement of the parity-violating asymmetry A_{PV} in the elastic scattering of longitudinally polarized electrons from ^{208}Pb. We measure A_{PV}=550±16(stat)±8(syst) parts per billion, leading to an extraction of the neutral weak form factor F_{W}(Q^{2}=0.00616 GeV^{2})=0.368±0.013. Combined with our previous measurement, the extracted neutron skin thickness is R_{n}-R_{p}=0.283±0.071 fm. The result also yields the first significant direct measurement of the interior weak density of ^{208}Pb: ρ_{W}^{0}=-0.0796±0.0036(exp)±0.0013(theo) fm^{-3} leading to the interior baryon density ρ_{b}^{0}=0.1480±0.0036(exp)±0.0013(theo) fm^{-3}. The measurement accurately constrains the density dependence of the symmetry energy of nuclear matter near saturation density, with implications for the size and composition of neutron stars.
Collapse
Affiliation(s)
- D Adhikari
- Idaho State University, Pocatello, ID 83209, USA
| | - H Albataineh
- Texas A & M University-Kingsville, Kingsville, TX 78363, USA
| | - D Androic
- University of Zagreb, Faculty of Science
| | - K Aniol
- California State University, Los Angeles, Los Angeles, California 90032, USA
| | | | - T Averett
- William & Mary, Williamsburg, Virginia 23185, USA
| | | | - S Barcus
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Bellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Catania, 95123 Catania, Italy
| | | | - J F Benesch
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Bhatt
- Mississippi State University, Mississippi State, MS 39762, USA
| | | | - D Bhetuwal
- Mississippi State University, Mississippi State, MS 39762, USA
| | - B Blaikie
- University of Manitoba, Winnipeg, MB R3T2N2 Canada
| | - Q Campagna
- William & Mary, Williamsburg, Virginia 23185, USA
| | - A Camsonne
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - G D Cates
- University of Virginia, Charlottesville, VA 22904, USA
| | - Y Chen
- Louisiana Tech University, Ruston, LA 71272 USA
| | - C Clarke
- Stony Brook, State University of New York, NY 11794, USA
| | - J C Cornejo
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - S Covrig Dusa
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Datta
- University of Connecticut, Storrs, CT 06269, USA
| | - A Deshpande
- Stony Brook, State University of New York, NY 11794, USA
- Center for Frontiers in Nuclear Science, NY 11794, USA
| | - D Dutta
- Mississippi State University, Mississippi State, MS 39762, USA
| | - C Feldman
- Stony Brook, State University of New York, NY 11794, USA
| | - E Fuchey
- University of Connecticut, Storrs, CT 06269, USA
| | - C Gal
- University of Virginia, Charlottesville, VA 22904, USA
- Stony Brook, State University of New York, NY 11794, USA
- Center for Frontiers in Nuclear Science, NY 11794, USA
| | - D Gaskell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T Gautam
- Hampton University, Hampton, Virginia 23668, USA
| | - M Gericke
- University of Manitoba, Winnipeg, MB R3T2N2 Canada
| | - C Ghosh
- Stony Brook, State University of New York, NY 11794, USA
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - I Halilovic
- University of Manitoba, Winnipeg, MB R3T2N2 Canada
| | - J-O Hansen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - F Hauenstein
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - W Henry
- Temple University, Philadelphia, PA 19122, USA
| | - C J Horowitz
- Indiana University, Bloomington, Indiana 47405, USA
| | - C Jantzi
- University of Virginia, Charlottesville, VA 22904, USA
| | - S Jian
- University of Virginia, Charlottesville, VA 22904, USA
| | - S Johnston
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - D C Jones
- Temple University, Philadelphia, PA 19122, USA
| | - B Karki
- Ohio University, Athens, Ohio 45701, USA
| | - S Katugampola
- University of Virginia, Charlottesville, VA 22904, USA
| | - C Keppel
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P M King
- Ohio University, Athens, Ohio 45701, USA
| | - D E King
- Syracuse University, Syracuse, New York 13244, USA
| | - M Knauss
- Duquesne University, 600 Forbes Avenue, Pittsburgh, PA 15282, USA
| | - K S Kumar
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - T Kutz
- Stony Brook, State University of New York, NY 11794, USA
| | | | - G Leverick
- University of Manitoba, Winnipeg, MB R3T2N2 Canada
| | - H Liu
- University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - N Liyange
- University of Virginia, Charlottesville, VA 22904, USA
| | - S Malace
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Mammei
- University of Winnipeg, Winnipeg, MB R3B2E9 Canada
| | - J Mammei
- University of Manitoba, Winnipeg, MB R3T2N2 Canada
| | - M McCaughan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D McNulty
- Idaho State University, Pocatello, ID 83209, USA
| | - D Meekins
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Metts
- William & Mary, Williamsburg, Virginia 23185, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M M Mondal
- Stony Brook, State University of New York, NY 11794, USA
- Center for Frontiers in Nuclear Science, NY 11794, USA
| | | | | | - D Nikolaev
- Temple University, Philadelphia, PA 19122, USA
| | - M N H Rashad
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Owen
- William & Mary, Williamsburg, Virginia 23185, USA
| | - C Palatchi
- University of Virginia, Charlottesville, VA 22904, USA
- Center for Frontiers in Nuclear Science, NY 11794, USA
| | - J Pan
- University of Manitoba, Winnipeg, MB R3T2N2 Canada
| | - B Pandey
- Hampton University, Hampton, Virginia 23668, USA
| | - S Park
- Stony Brook, State University of New York, NY 11794, USA
| | - K D Paschke
- University of Virginia, Charlottesville, VA 22904, USA
| | - M Petrusky
- Stony Brook, State University of New York, NY 11794, USA
| | - M L Pitt
- Virginia Tech, Blacksburg, Virginia 24061, USA
| | | | | | - B Quinn
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - R Radloff
- Ohio University, Athens, Ohio 45701, USA
| | - S Rahman
- University of Manitoba, Winnipeg, MB R3T2N2 Canada
| | - A Rathnayake
- University of Virginia, Charlottesville, VA 22904, USA
| | - B T Reed
- Indiana University, Bloomington, Indiana 47405, USA
| | - P E Reimer
- Physics Division, Argonne National Laboratory, Lemont, Il 60439
| | - R Richards
- Stony Brook, State University of New York, NY 11794, USA
| | - S Riordan
- Physics Division, Argonne National Laboratory, Lemont, Il 60439
| | - Y Roblin
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Seeds
- University of Connecticut, Storrs, CT 06269, USA
| | - A Shahinyan
- A. I. Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan 0036, Armenia
| | - P Souder
- Syracuse University, Syracuse, New York 13244, USA
| | - L Tang
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Hampton University, Hampton, Virginia 23668, USA
| | - M Thiel
- Institut für Kernphysik, Johannes Gutenberg-Universität, Mainz 55122, Germany
| | - Y Tian
- Syracuse University, Syracuse, New York 13244, USA
| | | | - E W Wertz
- William & Mary, Williamsburg, Virginia 23185, USA
| | - B Wojtsekhowski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Yale
- William & Mary, Williamsburg, Virginia 23185, USA
| | - T Ye
- Stony Brook, State University of New York, NY 11794, USA
| | - A Yoon
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - A Zec
- University of Virginia, Charlottesville, VA 22904, USA
| | - W Zhang
- Stony Brook, State University of New York, NY 11794, USA
| | - J Zhang
- Stony Brook, State University of New York, NY 11794, USA
- Center for Frontiers in Nuclear Science, NY 11794, USA
- Shandong University, Qingdao, Shandong 266237, China
| | - X Zheng
- University of Virginia, Charlottesville, VA 22904, USA
| |
Collapse
|
37
|
Horst C, Dickson J, Tisi S, Hall H, Verghese P, Mullin A, Farrelly L, Levermore C, Gyertson K, Clarke C, Allen B, Hamilton S, Hartman A, Nair A, Devaraj A, Hackshaw A, Janes S. P41.04 The SUMMIT Study: Pulmonary Nodule and Incidental Findings in the First 10,000 Participants of a Population-Based Low-Dose CT Screening Study. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.818] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
38
|
Hill M, Farrelly N, Clarke C, Cannon M. Student Mental Health and Wellbeing: Overview and Future Directions - Erratum. Ir J Psychol Med 2021:1. [PMID: 33475478 DOI: 10.1017/ipm.2020.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
39
|
Kalla R, Adams AT, Ventham NT, Kennedy NA, White R, Clarke C, Ivens A, Bergemalm D, Vatn S, Lopez-Jimena B, Ricanek P, Vatn MH, Söderholm JD, Gomollón F, Nowak JK, Jahnsen J, Halfvarson J, McTaggart S, Ho GT, Buck A, Satsangi J. Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease. J Crohns Colitis 2020; 14:1724-1733. [PMID: 32598439 DOI: 10.1093/ecco-jcc/jjaa134] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
BACKGROUND MicroRNAs [miRNAs] are cell-specific small non-coding RNAs that can regulate gene expression and have been implicated in inflammatory bowel disease [IBD] pathogenesis. Here we define the cell-specific miRNA profiles and investigate its biomarker potential in IBD. METHODS In a two-stage prospective multi-centre case control study, next generation sequencing was performed on a discovery cohort of immunomagnetically separated leukocytes from 32 patients (nine Crohn's disease [CD], 14 ulcerative colitis [UC], eight healthy controls) and differentially expressed signals were validated in whole blood in 294 patients [97 UC, 98 CD, 98 non-IBD, 1 IBDU] using quantitative PCR. Correlations were analysed with phenotype, including need for early treatment escalation as a marker of progressive disease using Cox proportional hazards. RESULTS In stage 1, each leukocyte subset [CD4+ and CD8+ T-cells and CD14+ monocytes] was analysed in IBD and controls. Three specific miRNAs differentiated IBD from controls in CD4+ T-cells, including miR-1307-3p [p = 0.01], miR-3615 [p = 0.02] and miR-4792 [p = 0.01]. In the extension cohort, in stage 2, miR-1307-3p was able to predict disease progression in IBD (hazard ratio [HR] 1.98, interquartile range [IQR]: 1.20-3.27; logrank p = 1.80 × 10-3), in particular CD [HR 2.81; IQR: 1.11-3.53, p = 6.50 × 10-4]. Using blood-based multimarker miRNA models, the estimated chance of escalation in CD was 83% if two or more criteria were met and 90% for UC if three or more criteria are met. INTERPRETATION We have identified and validated unique CD4+ T-cell miRNAs that are differentially regulated in IBD. These miRNAs may be able to predict treatment escalation and have the potential for clinical translation; further prospective evaluation is now indicated.
Collapse
Affiliation(s)
- R Kalla
- MRC Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK
| | - A T Adams
- Translational Gastroenterology Unit, Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, UK
| | - N T Ventham
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
| | - N A Kennedy
- Exeter IBD and Pharmacogenetics group, University of Exeter, Exeter, UK
| | - R White
- Institute of Immunology and Infection Research and Centre for Immunity, Infection & Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh, UK
| | - C Clarke
- LifeArc, Nine Edinburgh Bioquarter, Edinburgh, UK
| | - A Ivens
- Institute of Immunology and Infection Research and Centre for Immunity, Infection & Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh, UK
| | - D Bergemalm
- Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
| | - S Vatn
- Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway
| | | | | | - P Ricanek
- Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - M H Vatn
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Johan D Söderholm
- Department of Surgery and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
| | - F Gomollón
- HCU 'Lozano Blesa', IIS Aragón, Zaragoza, Spain
| | - J K Nowak
- Translational Gastroenterology Unit, Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, UK.,Department of Paediatric Gastroenterology and Metabolic diseases, Poznan University of Medical Sciences, Poznan, Poland
| | - J Jahnsen
- Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - J Halfvarson
- Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
| | - S McTaggart
- LifeArc, Nine Edinburgh Bioquarter, Edinburgh, UK
| | - G T Ho
- MRC Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK
| | - A Buck
- Institute of Immunology and Infection Research and Centre for Immunity, Infection & Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh, UK
| | - J Satsangi
- Translational Gastroenterology Unit, Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, UK.,Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
| |
Collapse
|
40
|
Spyropoulos F, Clarke C, Kurukji D, Norton IT, Taylor P. Emulsifiers of Pickering-like characteristics at fluid interfaces: Impact on oil-in-water emulsion stability and interfacial transfer rate kinetics for the release of a hydrophobic model active. Colloids Surf A Physicochem Eng Asp 2020. [DOI: 10.1016/j.colsurfa.2020.125413] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
41
|
Abstract
The mental health of third-level students is of major societal concern with the gap between the demand for services and supports offered at crisis level. In Ireland, similar to elsewhere, colleges have responded to this need in vastly differing ways, with student counselling services available to all institutions, and student health departments and sessional psychiatry in some of the larger institutions, with none operating as a single multidisciplinary service. There is an increasing recognition for a more systematised approach, with the establishment of International Networks, Charters and Frameworks. These advocate for a whole institutional approach to student mental health, in addition to the development of an integrated system of supports with effective pathways to appropriate care. This paper, by members of the Youth and Student Special Interest Group of the College of Psychiatrists of Ireland, contextualises student mental health currently and describes future directions for this emerging field. It is a call to action to develop a structure that supports the needs of students with mental health problems across the full range of the spectrum from mild to severe.
Collapse
Affiliation(s)
- M Hill
- Consultant Psychiatrist and University Lead for Student Mental Health and Wellbeing, University College Cork, Cork, Ireland
| | - N Farrelly
- Consultant General Adult Psychiatrist, College Health Service, Trinity University College Dublin, Dublin 2, Ireland
| | - C Clarke
- Senior Registrar in Psychiatry, Dublin North Mental Health Services, Dublin 9, Ireland
| | - M Cannon
- Consultant General Adult Psychiatrist Beaumont Hospital, and Professor of Youth Mental Health, Royal College of Surgeons, Dublin 2, Ireland
| |
Collapse
|
42
|
Sweeney L, Wolverson E, Clarke C. Understanding the shared experiences of creating a digital life story with individuals with dementia and their spouse. Dementia (London) 2020; 20:1791-1813. [PMID: 33131329 DOI: 10.1177/1471301220970403] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
INTRODUCTION Life story books in dementia are used as a part of person-centred care. Whilst the current literature demonstrates associations between completing life story books and increased well-being, little is known about the process and how it is experienced by individuals living with dementia. Life stories are often created with a loved one, such as a partner or spouse; however, further research is required to explore experiences of life story work as a shared endeavour. Furthermore, the use of technology to create life stories is growing, with little known about how digital elements are experienced. This study aimed to understand these gaps by exploring the shared experiences of individuals with dementia and their partner/spouse creating a digital life story book. DESIGN AND METHODS Four couples participated in the six-week creation of their digital life story book. Following this, qualitative data relating to couples' experiences were collected via semi-structured interviews. FINDINGS Thematic analysis was used to interpret data and identified four superordinate themes relating to the shared experiences of creating their digital life story book: 'Creating a life story book is a huge undertaking', 'Looking back and looking forward: The emotional journey', 'Whose story is it and who does it belong to?' and 'Challenges of using technology to build the life story book'. CONCLUSIONS Overall, this study demonstrated that creating a digital life story was a positive experience that can support couples' well-being, but we should not underestimate the time it will take and range of emotions experienced. The experience of using technology varied, emphasising that we must be mindful of individual preferences before considering a digital approach.
Collapse
Affiliation(s)
- Laura Sweeney
- Department of Psychological Health, Wellbeing and Social Work, 4019University of Hull, UK
| | - Emma Wolverson
- Department of Psychological Health, Wellbeing and Social Work, 4019University of Hull, UK
| | - Christopher Clarke
- Department of Psychological Health, Wellbeing and Social Work, 4019University of Hull, UK
| |
Collapse
|
43
|
Retzlaff A, Clarke C, Singh R, Mogal H, Mannem R, Fernando S, Charlson J, Bedi M. High Pre-Treatment Neutrophil-to-Lymphocyte Ratio is Associated with Poor Distant Metastasis-Free Survival in Patients with Soft Tissue Sarcoma of the Extremity. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.994] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
44
|
Clarke C, Spyropoulos F, Norton IT. A flow velocity dependence of dynamic surface tension in Plateau borders of foam. J Colloid Interface Sci 2020; 573:348-359. [PMID: 32298928 DOI: 10.1016/j.jcis.2020.04.028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2019] [Revised: 04/05/2020] [Accepted: 04/06/2020] [Indexed: 11/24/2022]
Abstract
HYPOTHESIS Liquid drainage through foams is a multiscale process, that primarily occurs through channels known as Plateau borders (PBs). Recent experimental studies of isolated PBs have observed variations in channel surface tension, γ, with liquid flow rate, Q, for systems containing soluble low molecular weight surfactant (LMWS). The current study proposes that the dynamic surface tension (DST) could be responsible for this effect, where the residence time of surfactant molecules in the PB is similar to the time required for their adsorption to the channel interface. EXPERIMENTS Profile geometries of isolated 'ideal' PB's were created in a bespoke experimental setup at controlled forced liquid flow rates. Average surfactant residence times, τRes, were calculated for solutions of Sodium dodecylsulfate (SDS), Tween 20 (T20) and Tween 80 (T80), and used to calculate corresponding average DST values in discrete regions of measured PB profiles. DST values were combined with microscale drainage theory to assess the potential physical implications on liquid flow. FINDINGS Significant variations in the magnitude of γ were calculated based on surfactant characteristics, where only the rapid adsorption of SDS was sufficient to produce DST values approaching equilibrium. These findings seriously question assumptions of near equilibrium surface tension in LMWS foam systems above their critical micelle concentration (CMC). Furthermore, the presence of surface tension gradients identified using this discrete approach, highlights the need to further refine the current theory to a continuous approach incorporating Marangoni effects.
Collapse
Affiliation(s)
- Christopher Clarke
- Department of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
| | - Fotis Spyropoulos
- Department of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
| | - Ian T Norton
- Department of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
| |
Collapse
|
45
|
Sweeney L, Clarke C, Wolverson E. The use of everyday technologies to enhance well-being and enjoyment for people living with dementia: A systematic literature review and narrative synthesis. Dementia (London) 2020; 20:1470-1495. [PMID: 32539471 DOI: 10.1177/1471301220929534] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Everyday technologies, such as laptops and tablets, are often used for enjoyment, pleasure, leisure and social participation. Despite this, whilst considerable research has investigated exploring people's experiences of using assistive technologies, it is not clear how everyday technologies are experienced by individuals living with dementia. The aims of this review were to explore the experiences and views of people living with dementia and carers about using everyday technology to enhance their well-being and enjoyment, social engagement, participation and leisure as well as understand their views about the usability of everyday technology in dementia. METHODS A systematic search of the literature was conducted using the electronic databases: PsycINFO, PsycARTICLES, CINAHL Complete and EThOS. Five qualitative studies and five mixed-method studies were included and synthesised using a narrative approach. The methodological quality of the studies was assessed using the National Institute for Health and Care Excellence Qualitative Quality Appraisal, which uncovered key variation in the quality of the included, synthesised studies. FINDINGS The review suggests that everyday technologies can help support well-being, particularly when technology is used in a group setting and when individuals received the right amount of support to help engage in the technology. Four major themes relating to experiences and views were derived from the findings of the 10 included studies: 'Technology use maintaining a sense of identity', 'Assumptions held by the self and others', 'The importance of others' and 'The usability of technology influencing effective engagement'. CONCLUSIONS Overall, everyday technologies appear to have a positive impact on different aspects of the well-being of people living with dementia. Clinical implications of these findings include supporting opportunities for people living with dementia to use everyday technology for enjoyment and making these technologies more widely available and accessible.
Collapse
Affiliation(s)
- Laura Sweeney
- Department of Psychological Health, Wellbeing and Social Work, University of Hull, Hull, UK
| | - Christopher Clarke
- Department of Psychological Health, Wellbeing and Social Work, University of Hull, Hull, UK
| | - Emma Wolverson
- Department of Psychological Health, Wellbeing and Social Work, University of Hull, Hull, UK
| |
Collapse
|
46
|
Carolan C, Clarke C, Girling C, Edenborough F, Curley R, Wildman M. P322 Using the CFHealthHub digital health system to provide distance nebuliser adherence support: a 6-month service evaluation comparing uptake and changes in adherence from support offered within normal working hours compared to in the evening. J Cyst Fibros 2020. [DOI: 10.1016/s1569-1993(20)30651-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
47
|
Abstract
Dominant discourses surrounding dementia tend to focus on narratives of loss and decline. Simultaneously, individuals living with dementia are vulnerable to being dispossessed of personal narratives supportive of identity and well-being. How older people with dementia story their experiences of resilience in this context has not previously been investigated. In response, this qualitative study utilised a narrative approach to understand lived experiences of resilience shared by eight older people living with dementia. Structural analyses indicated that participants' personal narratives regarding resilience in living with dementia contained distinct and common phases (The Diagnosis, Initial Tasks, 'The High Point', Reflecting on Limitations and Focusing on Today) as well as a variety of dynamic characters. Overarching themes within participants' narratives included sense of self/identity, being connected to others, sense of agency and having positive attitudes. Participants narrated richer, more active personal stories than those typically represented in dominant social discourses surrounding dementia. As such, their narratives depict lived experiences of resilience that unfolded over time in response to adversity and uncertainty and involved a dialectical process in relation to adjustment and well-being. The findings have important implications for the way resilience in living with dementia is framed and supported.
Collapse
|
48
|
Colindres R, Wascotte V, Brecx A, Clarke C, Hervé C, Kim JH, Levin MJ, Oostvogels L, Zahaf T, Schuind A, Cunningham AL. Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials. Hum Vaccin Immunother 2020; 16:2628-2633. [PMID: 32347767 PMCID: PMC7733973 DOI: 10.1080/21645515.2020.1741312] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
In two large clinical trials (ZOE-50 [NCT01165177] and ZOE-70 [NCT01165229]), two doses of the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy against herpes zoster in adults ≥50 years of age. Solicited adverse events (AEs) were collected for 7 days post-each dose in a study sub-cohort. The incidence of reported solicited AEs was higher for RZV compared to placebo recipients. Since reactogenicity may contribute to a person's willingness to be vaccinated, knowing about expected reactogenicity might help keep high compliance with the second dose. This post hoc analysis assessed the intensity of solicited AEs post-dose 2 reported to the same event's intensity post-dose 1. Intensity was graded from 0 to 3, grade 3 indicating the highest severity. Of the vaccinees who did not experience a specific AE post-dose 1, 72.6-91.7% did not experience the same event after dose 2. Although the frequency of grade 3 AEs post-dose 2 was the highest in participants reporting the same AEs at grade 3 post-dose 1, 65.8-89.3% of vaccinees with grade 3 specific AEs post-dose 1 reported the same AEs at lower intensity post-dose 2. These data can help inform health-care professionals about the frequency and intensity of AEs post-dose 2 with respect to post-dose 1.
Collapse
Affiliation(s)
- Romulo Colindres
- GSK , Rockville, MD, USA.,independent Biotech and Vaccines Consultant
| | | | | | | | | | | | - Myron J Levin
- Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus , Aurora, CO, USA
| | | | | | | | - Anthony L Cunningham
- The Westmead Institute for Medical Research, University of Sydney , Sydney, Australia
| |
Collapse
|
49
|
Horst C, Dickson J, Tisi S, Hall H, Mullin AM, Farrelly L, Gyertson K, Levermore C, Steele R, Knights T, Clarke C, Allen B, Hamilton S, Hartmann AR, Nair A, Devaraj A, Hackshaw A, Janes S. SUMMIT study: protocolised management of pulmonary nodules in a lung cancer screening cohort. Lung Cancer 2020. [DOI: 10.1016/s0169-5002(20)30034-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
50
|
Colindres R, Wascotte V, Brecx A, Clarke C, Hervé C, Hyung Kim J, Levin MJ, Oostvogels L, Zahaf T, Schuind A, Cunningham AL. 2780. Reactogenicity Profile of Adjuvanted Recombinant Zoster Vaccine after Dose 2 According to the Intensity of the Same Event Experienced after Dose 1. Open Forum Infect Dis 2019. [PMCID: PMC6810576 DOI: 10.1093/ofid/ofz360.2457] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
In the pivotal clinical trials, ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229), the adjuvanted recombinant zoster vaccine (RZV) showed high efficacy against herpes zoster and postherpetic neuralgia. The incidence of reported solicited events was higher in RZV compared with placebo recipients.
Methods
In these phase III, observer-blind, placebo-controlled trials conducted in 18 countries, adults ≥50 years of age (YOA, ZOE-50) and ≥70 YOA (ZOE-70), randomized 1:1, received 2 doses of RZV or placebo 2 months apart. Injection-site and general events were solicited for 7 days after each dose via diary cards in a participant subset. For this post-hoc analysis, ZOE-50 and ZOE-70 data from participants having completed the diary cards for both RZV doses were pooled. The intensity of each solicited event after dose 2 was stratified by the intensity of the same event after dose 1.
Results
Solicited injection-site and general events were recorded for both RZV doses by 4,676 and 4,668 vaccinees, respectively (Figure 1). Of 1,235 vaccinees with no injection-site event at dose 1, 881 (71.3%) reported no injection-site event and 20 (1.6%) reported a grade 3 event after dose 2. A total of 433 (9.3%) vaccinees reported a grade 3 injection-site event, either after dose 1 or dose 2. Of 244 vaccinees with grade 3 injection-site events at dose 1, 79 (32.4%) also reported a grade 3 event after dose 2. Of 2,312 vaccinees with no general event at dose 1, 1,617 (69.9%) reported no general event and 67 (2.9%) reported a grade 3 event after dose 2. A total of 499 (10.7%) vaccinees reported a grade 3 general event, either after dose 1 or dose 2. Of 222 vaccinees with grade 3 general events at dose 1, 81 (36.5%) also reported a grade 3 general event after dose 2. In general, vaccinees who did not experience a certain event after dose 1, did not experience this event after dose 2 either. Most vaccinees reporting a specific event at high intensity after dose 1, reported the same event at a lower intensity (or not at all) after dose 2 (Figures 2 and 3).
Conclusion
While not powered to predict event intensity of the second RZV dose, our data provides an overview of event intensity after RZV dose 2 according to the intensity of the same event experienced after dose 1.
Funding: GlaxoSmithKline Biologicals SA.
Disclosures
All authors: No reported disclosures.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Myron J Levin
- University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | | | | | | | - Anthony L Cunningham
- The Westmead Institute for Medical Research and the Institute’s Centre for Virus Research, The University of Sydney, Sidney, New South Wales, Australia
| |
Collapse
|